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Abstract
Nanostructured-Initiator Mass Spectrometry (NIMS), which uses ‘initiator’
molecules trapped within a nanostructured material to assist the release and ionization of
intact molecules adsorbed on that material's surface upon laser or ion irradiation, is a new
soft desorption/ ionization technique with several positive attributes including
extraordinarily high detection sensitivities, relatively simple sample preparation protocols,
and can be initiated using photon or ion irradiation sources. As a result NIMS has a great
deal of potential for the ready detection of small molecules from complex biofluids
including metabolites, and for tissue imaging.
In the thesis, a variety of nanostructured materials including porous silicon (pSi),
WO3 and TiO2 were fabricated with a home-made apparatus as substrates for NIMS. The
benefit of pSi-based NIMS using BisF17 as an initiator over Desorption Ionization On
Silicon (DIOS) and Matrix-Assisted Laser Desorption Ionization (MALDI) mass
spectrometry (MS) was demonstrated by comparing the signal intensities of protonated
polypeptide Dalargin, using the three techniques. A wide range of biological and
pharmaceutical compounds were analyzed by NIMS that ionize in different ways to
illustrate the versatility of this method.
Secondly, a fluorous-affinity NIMS chip was developed using a fluorous tag
containing a 3-(perfluorooctyl)-propyl-1-maleimide moiety, to selectively capture
peptides that contain cysteine residues. The fluorous tag was held to the NIMS chip by
non-covalent fluorine-fluorine interactions. This methodology was utilized to effectively
separate and enrich on-chip cysteine-containing peptides from mixtures, perform kinases
(PKA and Abl) activity assays, as well as to quantitatively analyze enzymatic inhibition.
iii

It was shown that fluorous-affinity NIMS chips have the potential to be used as high
throughput enzyme inhibitor screening methodology for drug discovery. Fluorous NIMS
chips were also shown to be able to measure the enantiomeric excess (ee) of chiral
analytes based on kinetic resolution.
An exploration of new micro/nanostructured substrates and laser sources for
NIMS was also carried out using microstructured WO3 and porous TiO2, and the 532 nm
output of a frequency-doubled Nd-YAG laser. It was shown that NIMS mass spectra of
peptide (Dalargin) with good intensity could be obtained by these substrates and visible
laser source using BisF17 as an initiator.
Lastly, the Surface-Assisted Laser Desorption Ionization (SALDI) mechanism
was investigated by measuring the ion signal, I, as a function of laser fluence, F.
Evidence is presented that shows that desorption is driven by a thermal process, and
desorption activation energies were derived for pSi, WO3 and TiO2, respectively. A new
ionization mode, Surface Assisted Multiphoton Ionization (SAMPI), is postulated that
explains the observation of radical cations and the strong dependence of these ion signals
on the position of laser focus relative to the substrate surface. The SAMPI mechanism
which appears to be generic for all the porous SALDI substrates studied in this thesis,
may prove to be useful for delivering biomolecules into the gas-phase for spectroscopy.
Keywords: Nanostructured-Initiator Mass Spectrometry (NIMS), Surface-Assisted Laser
Desorption/Ionization (SALDI), Surface-Assisted Multiphoton Ionization (SAMPI),
fluorous affinity biochip, enzymatic activity assay, enzyme inhibitor screening,
enantiomeric excess analyses, desorption/ionization mechanism, visible-NIMS, porous Si,
WO3 and TiO2.
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Chapter 1: Introduction
1.1: Background on Surface Assisted Laser Desorption/Ionization (SALDI)
1.1.1: The development and limitations of MALDI
Matrix Assisted Laser Desorption/Ionization (MALDI) is a soft ionization
technique discovered in the late 1980s which is widely utilized in mass spectrometry
(MS) [1, 2]. It employs a solid molecular matrix which absorbs an incident laser energy
and assists in the desorption and ionization of analytes imbedded within. In general, a
matrix consists of small organic molecules or inorganic nanoparticle suspensions, and
plays a crucial role in formation of intact gas-phase analyte ions. For example, the matrix
prevents the analyte imbedded within the matrix from being photochemically and/ or
thermally degraded when the solid solution undergoes a phase transition from solid to
gas under laser irradiation. It also prevents analyte molecules from aggregating by
dilution within the solid solution [3]. Therefore MALDI MS has greatly expanded the
applications of mass spectrometry for the analysis of a wide variety of compounds,
especially large thermally labile biomolecules and synthetic polymers [4].
MALDI MS, however, has several well-known limitations including the need to
have a variety of matrices on hand to study different classes of analyte molecules, the
presence of ‘sweet spots’; that is, areas of the solid solution which produce more intense
MALDI signals than others due to the uneven distribution of analytes within the matrix,
and matrix interferences at low m/z values. The choice of a suitable matrix, which is
typically determined by trial and error, is an extremely laborious but a vital step towards
optimizing a MALDI spectrum because it influences the analyte ionization efficiency, the
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mass resolution and the detection sensitivity. While there are a number of matrices which
have been tested for different incident laser wavelengths and analyte types which can be
used for some guidance, the selection process remains empirical [3]. The phenomenon of
“sweet spots”, resulting in shot-to-shot ion signal variability is due in part to the method
of preparation selected to make the solid solution [5]. Lastly, the MALDI technique
suffers from excessive matrix background signals in the low molecular weight
(mass/charge, m/z < 1000) region of the mass spectrum. This background due to matrix
ion fragments, clusters, and adducts obscures the ion signals from low molecular weight
molecules of interest such as drug metabolites and small peptides. Moreover, the high
abundance of matrix-related ions in the laser plume can lead to signal suppression and
compromise the detection sensitivity for low-abundance analytes [6-8].
There has been considerable interest in developing matrix-free SALDI techniques
to minimize or eliminate these problems. The most prevalent one for the analysis of small
molecules is desorption/ionization on silicon (DIOS) [9]. However, other solid substrates
have also been tested including sol-gels [10], carbon-based microstructures [11, 12], and
metal-based nanostructure substrates [13].
In DIOS, porous Si (pSi) is used to assist in the ionization of analyte molecules
instead of a MALDI matrix compound such as 2,5-dihydroxybenzoic acid, DHB and acyano-4-hydroxycinnamic acid, CHCA. Although not a commercial technique DIOS has
been successfully used to analyze a wide variety of samples including small drugs,
explosives, polymers, and forensic compounds [14, 15].
1.1.2: The development of DIOS
DIOS MS, introduced by the Siuzdak group in 1999, was the first truly matrix-
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free laser desorption/ionization mass spectrometric method. It involves spotting an
analyte onto a sample of pSi, as shown in the Fig. 1.1[9]. As a desorption/ionization
technique, DIOS offers good sensitivity, high tolerance to contaminants and no matrix
interferences. Furthermore this approach is compatible with silicon-based microfluidics
and microchip technologies [9].
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Fig. 1.1: Experimental configuration for a DIOS experiment [9].
Fig. 1.1: Experimental configuration for a DIOS experiment [9].
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A large number of DIOS-related methods have been subsequently developed. For
example, atmospheric pressure-desorption/ionization on silicon (AP-DIOS), was
introduced as a new analytical tool that is complementary to AP-MALDI [16] and shown
to be superior at m/z < 1,100. The combined data of both AP-DIOS and AP-MALDI
nearly doubled the number of identifiable mass spectral peaks in a bovine serum albumin
(BSA) digest analysis compared to that obtained separately by only one approach.
Silicon nanowires (SiNWs) have been used instead of pSi as an alternate platform
for DIOS-MS. Unlike a pSi surface, SiNWs are grown on the surface of a solid Si
substrate. Sensitivity down to the attomole (10-18 moles) level has been achieved using
these structures by optimizing the incident laser energy, Si surface chemistry, and the NW
diameter, length, and orientation relative to the underlying substrate. Due to their high
surface areas and fluid wicking capabilities, SiNWs are able to perform analyte
chromatography separations prior to mass spectrometric analysis, thereby providing a
unique platform that integrates these two functions on a single substrate [17].
The nanostructured silicon produced by electrochemical etching and laser
processing are characterized by a morphology consisting of an array of µm high Si
columns, each covered by nano-leaves. This morphology features a large surface area that
is relatively stable against UV laser damage, and therefore able to generate reproducible
DIOS mass spectra. This is expected to make DIOS suitable for routine analysis of low
molecular weight analytes [18].
1.1.3: Methods for fabricating porous silicon
A pSi surface is characterized by a large area and a nanostructured morphology.
The material can then be spotted with analyte and directly irradiated for laser desorption
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ionization MS with little or no background interference. So far, many different techniques
including electrochemical etching [19], laser-induced transformations [20], high-density
plasma deposition [21], reactive ion etching [22], and so on, have been used to produce
pSi substrates.
In this work pSi was fabricated by electrochemically etching bulk Si wafers in
dilute aqueous or ethanoic hydrofluoric acid (HF). Ethanol is frequently added to the
hydrofluoric acid to minimize hydrogen bubble formation during anodization. This
improves the pSi layer uniformity [23]. Electrochemical etching can be performed either
in a potentiostatic (voltage-controlled) or galvanostatic (current-controlled) mode. The
latter is normally preferred because it supplies the required charge for the reaction at
constant rate regardless of any changes in cell electrical impedance, ultimately leading to
more homogeneous and reproducible material.
Other fabrications used to produce nanostructured silicon substrates include
nanosphere lithography-coupled reactive ion etching (RIE) which can be used to generate
a regular microstructured surface [24]. A Au nanocluster-catalyzed vapour-liquid-solid
(VLS) growth mechanism was used to produce dense arrays of single-crystal SiNWs
platform for DIOS detection of small molecules, peptides, protein digests, and
metabolites in biofluids [17]. Plasma-enhanced chemical vapour deposition (PECVD) can
be used to form novel thin films consisting of a column/void-network of deposited silicon
that does not require etching prior to its use for DIOS [21].
1.1.4: Applications of DIOS
The utility of DIOS for the analysis of small molecules, protein identification and
functional characterization, and polymer analysis has been studied. The analysis of small
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biomolecules such as drugs is one of the strengths of DIOS combined with MS due to the
elimination of the matrix and subsequent matrix-related interferences [9, 15, 25]. DIOS
combined with proteolytic digestion and database searching allows proteins and posttranslational modifications to be identified. For example, on-plate digestion and DIOS
with mass detection was used to identify the acetylcholine esterase (Ache) enzyme [26].
The potential that DIOS-MS has for making reliable quantitative analyses of polymers
makes it promising for biological forensics. For example, DIOS-MS have been used to
analyze ethoxylate polymers present in a contraceptive lubricant [14].
Since DIOS is a matrix-free desorption technique, it has the potential to monitor
sequential reactions on the same surface via multiple mass spectrometric measurements.
For example, DIOS-MS was used to determine the enantiomeric excess of a synthetic
process during drug development [27]. It has also the potential to be used to measure the
enantiomeric excess in high throughput systems to establish optimum reaction conditions
quickly and easily [28]. Lastly, DIOS MS has been used as direct assays of tissues and
cells.[29].
1.2: The overview of Nanostructured-Initiator Mass Spectrometry (NIMS)
1.2.1: Fundamental characteristics of NIMS
In 2007, the Siuzdak group introduced NIMS, which uses ‘initiator’ molecules
trapped in a nanostructured surface like pSi to release and ionize intact adsorbed
molecules on the surface. This approach overcomes the limitations that DIOS has in terms
of robustness and reproducibility, which has limited its use to date [30]. NIMS takes
advantage of the basic physical properties of the pSi DIOS platform such as its ability to
absorb light and its low thermal conductivity to perform rapid surface heating and trigger
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the desorption of adsorbed molecules. At the same time, NIMS also incorporates some
features which are similar to MALDI such as the use of a liquid initiator like a fluorinated
siloxane to facilitate desorption due to its sensitivity to temperature. However, unlike a
matrix the initiator does not absorb laser energy due to its transparency to UV light, and
thus are not ionized themselves. Furthermore, they are also not co-crystallized or
incorporated with the analyte molecules [31]. Conceptually NIMS can be viewed as the
inverse of one of the first MALDI experiments that involved the use of nanoparticles
matrixes suspended in glycerol [2]. Furthermore NIMS is considerably softer than
MALDI [3]. As shown in Fig. 1.2, in a typical NIMS process, after the pSi has absorbed
the incident laser energy that causes rapid surface heating, the trapped initiator is
vaporized, facilitating the desorption of the analyte without fragmentation [32].
NIMS has some exceptional features. For example, many different types of
irradiation sources such as a N2 laser and various ion sources (Au+, Ga+, Bi+ and Bi3+)
have been found to produce NIMS activity. In general, a typical NIMS surface is
composed of ~10 nm pores fabricated by electrochemically etching pSi on a bulk silicon
wafer, (Section 1.1.3). A variety of NIMS initiator molecules have been successfully used
with molecular weights ranging from 200 to 14,000 Da, including lauric acid,
polysiloxanes, siloxanes and silanes (Table 1.1). However, the performance of
perfluorinated siloxanes has been shown to be excellent for a wide range of analytes and
therefore, is preferred for laser-NIMS. The reason for this is that perfluorinated siloxanes
are effectively trapped within nanostructured pSi and have relatively low vapour
pressures making them compatible for use in the vacuum environment of most MALDI
instruments [31]. A higher molecular weight fluorinated siloxane (14,000 Da) is often
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Desorption/ionization
in NIMS

Mass analyzer

Mass spectrum

Ion

Intact analyte ion

Fig.1.2: Schematic diagram of a typical NIMS analysis [30]

chosen for ion-initiated NIMS due to their very low vapour pressures; a necessity for use
in time-of-flight-secondary-ion mass spectrometry (TOF-SIMS) instruments that have
more stringent vacuum requirements [30]. It is essential that any initiator chosen does not
absorb the incident laser energy and ionize to avoid introducing chemical noise into the
mass spectra [32].

9

Table 1.1: Compounds utilized as a NIMS initiator
Name, molecular formula,
molecular weight

Chemical structure

References
[33]

Bis(heptadecafluoro-1,1,2,2tetrahydrodecyl)tetramethyldisiloxane, C24H20F34OSi2,
1026.5
[34]
Bis(tridecafluoro-1,1,2,2tetrahydrooctyl)tetramethyldisiloxane, C20H20F26OSi2,
826.5
[31]
Pentafluorophenylpropyldimeth
yl-chlorosilane, C11H12ClF5Si,
302.7
[35]
(Heptadecafluoro-1,1,2,2tetrahydrodecyl)dimethylchlorosilane, C12H10ClF17Si,
540.7
[31]
(3-Phenylpropyl)dimethylchlorosilane, C11H17ClSi, 212.8

[30]
1,3Dioctyltetramethyldisiloxane,
C20H46OSi2, 358.7
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[30]
1,3-Bi(3-carboxypropyl)
tetramethyldisiloxane,
C12H26O5Si2, 306.5
[30]
1,3-Divinyl-1,3-diphenyl-1,3dimethydisiloxane, C18H22OSi2,
310.5

[30]
1,3-Bis(hydroxybutyl)
tetramethyl-disiloxane,
C12H30O3Si2, 278.5
[27]
3-Cyanopropyldimethylchlorosilane, C6H12ClNSi, 161.7
[31]
3-Aminppropyldimethylethoxysilane, C7H19NOSi, 161.3
[27]
1,3-Bis(3-aminopropyl)
tetramethyldisiloxane,
C10H28N2OSi2, 248.5
[30]
(Aminoethylamino)-3-isobutyldimethylmethoxysilane,
C9H24N2OSi, 204.1
[30]
Lauric acid, C12H24O2, 200.3
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[30]
1,3-Bis(3-methacryloxypropyl)
tetrakis(trimethylsiloxy)disiloxa
ne, C26H58O9Si6, 683.2

[30]

poly(3,3,3trifluoropropylmethylsiloxanes)fluorinated siloxane,
(C4H7F3OSi)n, 14 kDa

The advantages of NIMS over MALDI and the other surface desorption/ionization
techniques include a higher sensitivity (i.e. a detection limit of 700 ymole for a calcium
antagonist [30]), simpler sample preparation because analytes do not need to be
incorporated or co-crystallized with the initiator [36], and potentially a higher lateral
resolution (for ion-NIMS this can be as small as ~ 150 nm) [30]. Overall, NIMS also
exhibits better reproducibility and therefore is capable of performing sensitive, simple and
rapid analyses of highly complex biological tissues and fluids [37], and of characterizing
peptide microarrays and mass analyzing single cells [30]. NIMS has also been shown to
provide molecular specificity, sensitivity, and good resolution for imaging cholesterol
metabolites within biological tissues [38].
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1.2.2: The applications of NIMS
As shown in Fig. 1.3 the potential of NIMS for the detection of small molecules in
the analyses of complex biofluids, metabolites and tissue imaging is immense [34].
1.2.2.1: Complex biofluid analyses
Biofluids such as blood, urine and saliva are in many instances ideal diagnostic
samples because they can contain a wealth of biochemical information related to
pathology changes [39]. Typically, the nature and complexity of biofluid samples
necessitate sample preparation such as organic solvent extraction or chromatography
separation prior to conventional analyses such as gas chromatography (GC)/MS, high
performance liquid chromatography (HPLC)/MS or MALDI MS [40-42]. Conversely,
NIMS does not require prior sample preparation [37]. It has been demonstrated that
ketamine, a drug used in human and veterinary medicine, and its metabolite, norketamine,
could be analyzed by NIMS by directly spotting mouse urine and blood sample onto the
chip surface without any additional sample preparation except for removal of excess urine
or blood drops using a N2 gas stream [37]. Similarly, direct NIMS analysis of some
compounds from human saliva was also reported in the same article.
Furthermore, NIMS performance has been quantitatively evaluated using several
standard xenobiotics (methamphetamine, codeine, apralozam and morphine spiked into
rat serum). The limit-of-detection (LOD) values of all these analytes were in the attomole
range and their response curves were linear in the range between 1 ng/mL and 150 ng/mL
[37].

13

Fig.1.3: Illustration of some of the main applications of NIMS [34].
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The potential applicability of cation-NIMS analysis in a clinical setting was
demonstrated in a study which analyzed glucose and cholesterol in human serum. Here,
cations were deposited on the NIMS surface by electrospray before adding the initiator
[33]. It is well-known that carbohydrates and steroids are classes of important biological
active molecules that are hard to detect by current surface-based MS methods due to their
low ionization efficiencies [4, 43]. In general, they are more easily detected as cationic
adducts instead of protonated [A+H]+ species [44]. The concentration of glucose in
standard human serum obtained from Sigma-Aldrich was determined to be 4.1mM by
Na+- enhanced NIMS. The analyte detection exhibited good linearity (R2 = 0.9975)
between 1 µM and 200 µM [33]. Interestingly, steroids such as cholesterol were best
detected as silver adducts [A+Ag]+. In this way, Ag+- NIMS, used to quantitatively
analyze the amount of cholesterol in human serum, found the concentration of the steroid
to be ~4.2 mM (~164 mg/dL), which is within the normal cholesterol range of less than
200 mg/dL recommended by the American Heart Association [33].
1.2.2.2: Metabolites analysis
Although MALDI MS has been developed to be one of the most dominant
analysis tools in proteomics, there is still a formidable challenge in analyzing metabolites
due to interferences from the matrix. Metabolites closely correlate with an organism’s
phenotype [45] and include a wide variety of compounds such as amino acids, other
organic acids and amines, nucleotides, lipids, and sugars which are the downstream end
products of gene and protein activity. It was suggested that NIMS could provide a means
of studying metabolites due to its extremely high sensitivity, the absence of matrix
interference, and minimal sample preparation [30].
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Phospholipids (PLs) have been proved to be effective cancer biomarkers and cell
specific drug targets [46, 47]. It was demonstrated that laser-NIMS could be used to
analyze endogenous PLs from metabolites of few or even a single cell in a highly
metastatic breast cancer cell line [30]. Since the concentration of metabolites is often vital
in clinical assays, it is important to reiterate that NIMS method has ability to perform
direct quantitative analysis of metabolites from blood and urine [33, 37]. Laser-NIMS
with negative-ion mode detection was also used to detect endogenous cell metabolites of
phosphoenolpyruvate (PEP), 5’-guanylate diphosphate (GDP), adenosine 5’-triphosphate
(ATP), adenosine 5’-diphosphate (ADP), and guanosine 5’-triphosphate (GTP) [35].
Interestingly, the selection of initiator can significantly impact the ion profiles
observed in the mass spectrum of a biological sample. For example, there are
substantially different ion profiles in NIMS spectra of urine samples obtained using bis(heptadecafluoro-1,1,2,2- tetrahydrodecyl) tetramethyl-disiloxane as an initiator and a
more polar compounds such as 1,3-bis (hydroxybutyl) tetramethyldisiloxane [32].
1.2.2.3: NIMS imaging
NIMS is a powerful platform for MS imaging due to its high spatial resolution, an
extended usable mass range, minimal sample preparation, the absence of matrix
interferences and improved sensitivity [32]. For example, NIMS imaging of metabolites
in mouse embryo slices was done by first ablating the surface tissue with a high energy
laser (~ 0.4 J/cm2 per pulse), followed by direct interrogation of the interface between the
tissue and chip surface with low-energy irradiation (~ 0.01 J/cm2 per pulse) [30].
Cation-enhanced NIMS imaging has also been used to acquire the distribution of
sucrose in a flower stem and the distribution of cholesterol in a mouse brain [33].
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Furthermore, it was utilized for the first time to localize the perturbations to metabolism
within pathological brain tissue of mice having Smith–Lemli–Opitz Syndrome (SLOS) by
imaging cholesterol and its precursors. These results suggest a role for cholesterol
metabolites in the development of these brain regions and provide anatomical insight into
the SLOS disease pathology [38]. Overall, NIMS imaging is complementary to imaging
MALDI MS, which is better suited to the detection of peptides and small proteins in
tissue samples [48].
1.3: Immobilization method on chip surface
Currently one of the most cutting-edged biochemical analysis techniques is the
combination of affinity fractionation based on the surface chemistry of a biochip, with
label-free detection based on surface laser desorption/ionization mass spectrometry:
Surface-Enhanced Laser Desorption/Ionization (SELDI) [49]. This approach allows
enrichment and massively parallel analyses of particular subsets of analytes of interest
from small volumes of complex mixtures. The functionalized surface of the biochip plays
an active role by providing moieties that can immobilize specific target analytes, thereby
reducing nonspecific interactions of molecules in the sample with the chip surface [50].
According to a general or specific physicochemical property of the analyte of interest,
each biochip surface can be designed to immobilize specific molecules. A number of
immobilization methods have been developed to prepare biochips, including covalent
strategies such as a Michael addition reaction [51], silyl ether formation [52], etc. In
addition, non-covalent approaches can be used that take advantage of electrostatic
interactions [53], sequence-specific hybridizations [54], fluorous-base interactions [55],
and so on.
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1.3.1: Covalent immobilization
This immobilization strategy makes use of mild and chemically selective coupling
reactions to capture desired analyte molecules onto a derivatized chip surface. For
example, the first Small-Molecule Microarray (SMM) chip was prepared by a reaction to
form a maleimide-functionalized surface using a bifunctional linker, as shown in the
Fig.1.4a [51]. The treated biochip was then used to selectively capture compounds
containing a free thiol group by a simple Michael addition reaction, (Fig.1.4b) [56].
Other covalent immobilization methods include a chloro-silanated chip surface
which is produced by reacting SOCl2 with a glass surface. This substrate has been used to
bind primary alcohol but not secondary alcohols or phenols due to their relatively slow
reaction rates [57]. Similarly, an epoxide-coated chip surface has been used to capture
hydrazide-tagged analytes and carbohydrates [58]. Likewise, a diazobenzylidenefunctionalized surface was used to selectively immobilize acidic heteroatom-containing
compounds such as phenols, carboxylic acids or sulphonamides [59]. Many other
chemical reactions such as Diels–Alder cycloadditions, Staudinger Ligation and
photocrosslinking have also been used to covalently immobilize analytes on chip surfaces
[56].
1.3.2: Non-covalent immobilization
Non-covalent methods take advantage of adsorption phenomenon rather than
chemical reactions to immobilize an analyte. For example, carbohydrate-lectin
interactions were investigated using a chip on which carbohydrates with tails of saturated
carbon chains consisting of 13~15 carbons were attached as an array on a hydrophobic
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a)

b)

Fig.1.4a) a bifunctional linker covalently immobilized on the chip to form a
maleimide-functionalized surface; b) a reaction showing how the treated
biochip can be used to capture selectively a compound containing a thiol
group by simple Michael addition reaction [51, 56].
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surface [60]. In another strategy, a Peptide Nucleic Acid (PNA) tag containing a
covalently bound small molecule or bifunctional linker was anchored non-covalently onto
an oligonucleotide microarray chip surface by sequence-specific hybridization, as shown
in Fig.1.5a [54].
1.4: Fluorous affinity techniques
Recently a new non-covalent immobilization strategy based on fluorous-fluorous
interactions has been used to prepare small molecule microarrays for carbohydrate
analysis (Fig.1.5b)) [61]. Such fluorous-based microarray chips have also been used to
perform high-throughput enzymatic inhibitor screening for drug discovery [55].
1.4.1: The fundamental features of fluorous chemistry
Since the introduction of fluorous biphasic catalysis techniques in the middle of
1990s [62], the field of fluorine-based chemistry has expanded rapidly in organic
synthesis and purification [63, 64]. Recent innovations suggest that a wide range of
potential applications of fluorous tags technology could be realized in chemical biology
as well [65]. The word ‘fluorous’ refers to a bulk liquid phase distinct from organic
solvents; it is a third phase orthogonal to the organic and aqueous phases [66]. Since at
the molecular level, the perfluoroalkyl groups [–(CF2)n–] tend to repel organic and
inorganic molecules but have attractive interactions with other perfluoroalkyl (RFn)
groups, fluorous molecules can be separated from other molecules based on their CF2
content by several methods such as chromatography, liquid-liquid or solid-phase
extractions, etc. [65].
Interestingly, although in principle a fluorous phase is immiscible in both aqueous
and organic phases, the solubility of a fluorous compound in organic solvents is
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a)

b)

Fig.1.5: Representative examples of noncovalent immobilization used to
fabricate SMM chips: a) a schematic showing how libraries of small molecules
which are encoded by a specific PNA codon may be captured selectively onto an
oligonucleotide microarray by a hybridization reaction; b) a schematic showing
how a small polyfluorocarbon attaches non-covalently to a fluoroalkylsilanecoated chip surface [54, 61].
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dependent on temperature and the fluorine content of the whole molecule [67]. This
unique characteristic has been exploited in the development of fluorous tags for solutionphase syntheses and fluorous separations [68]. The fluorous phase methods can be seen as
green because fluorous materials can be recovered and recycled for use after separation
[67].
Typically, fluorous tags contain a perfluorinated domain (RFn) which is that
portion of the molecule used for fluorous separation or immobilization. It also contains a
parent molecule with a chemically reactive group and an alkyl segment (CH2)m that
connects the parent molecule to the fluorous group and insulates the reactive site on the
parent molecule from the electron-withdrawing fluorines. It is assumed that the
immobilization does not alter or completely eliminate the activity of the molecule, which
is a major concern for chip-based assays. In addition, the unique solvophobicity and
fluorophilicity of a fluorous phase can prevent nonspecific adsorption of protein, which
can often lead to denaturation and a subsequent loss of activity of the immobilized species
[69].
1.4.2: The application of fluorous tags on chemical biology
Recently, fluorous affinity technology has been used to separate proteins, to assay
enzymes (by NIMS) and to construct fluorous carbohydrate microarrays [61, 70, 71]. In
general, fluorous-affinity tags used for separation and enrichment operate in one of two
modes. The first is based on the use of a Fluorous Solid-Phase Extraction (F-SPE) column
where perfluoroalkyl chains serve as a bonded phase instead of a resin to facilitate analyte
separation (Fig.1.6a)). In fluorous proteomics separations, for example, a complex
peptide (or proteins) sample in solution is selectively labeled with a fluorous tag

22

containing a specific functional group and then loaded onto the fluorous solid-phase
medium for separation. The unbound species and contaminants are subsequently washed
away using a suitable organic solution. Finally, the desired bound species are eluted from
the affinity column for MS analysis [70, 72].
The second strategy is based on a biochip where the analytes of interest are
captured by a fluorous tag immobilized on a fluorous-silylated surface by fluorinefluorine interactions (Fig.1.6b)). In proof-of-principle experiments, a NIMS enzymatic
assay or Nimzyme was developed to detect both addition and cleavage reactions under
enzymatic catalysis of sialyltransferase and galactosidase with extremely high sensitivity
(sub-picogram levels), and to directly characterize the enzymatic activity of crude cell
lysates from thermophilic bacteria [71].
As mentioned previously, fluorous-affinity interactions have also been exploited
in the fabrication of small molecule microarrays. For example, fluorous-tagged
saccharides have been non-covalently immobilized on a fluorous slide surface for the
analysis of carbohydrates [61]. This arrangement was used to obtain information on the
binding of heptoses to lectins and to identify small molecule inhibitors of the histone
deacetylase enzyme [55, 73].
1.5: The goals of the thesis
The projects described in this dissertation are motivated by the desire to apply the
concepts developed from surface chemistry, fluorous chemistry and mass spectrometry to
develop biochips that can be used to investigate the interactions between biological
species and small molecules. The work in this thesis extends demonstrated concepts such
as the use of fluorous affinity tags F-SPE column chromatography to enrich and
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a

b

Fig. 1.6: Illustration of some main applications of fluorous affinity
technology: a) a F-SPE column which uses perfluoroalkyl chains as
bonded phase instead of a resin to facilitate analyte separation, is
employed to enrich and separate specific classes of peptides in fluorous
proteomics. Firstly it is selectively labelled with a fluorous tag and then
loaded onto a F-SPE column, followed by washing and collection based
on fluorine content; b) a Nimzyme assay process in which enzymatic
substrate with fluorous tags is immobilized onto NIMS chip surface by
fluorophilicity followed by incubation of the surface with the samples to
screen for enzymatic activity [65, 71].
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subsequently mass analyze peptide subsets from mixtures [70]. The work also exploits the
fact that fluorous liquid-coated NIMS surfaces can be used as tags to non-covalently
attach enzyme substrates for assays [71].
A flow chart detailing the goals of this thesis is shown in Fig. 1.7. In Chapter 1 the
background to understand various Surface Assisted Laser Desorption Ionization (SALDI)
techniques including NIMS is presented. Details regarding the experimental apparatus
used in this thesis are found in Chapter 2, as well as an assessement of the performance of
pSi chips fabricated using a home-built electrochemical etching set-up. An evaluation of a
NIMS chip based on a pSi substrate is provided in Chapter 3. Several new applications of
a fluorous affinity NIMS chip utlilizing a 3-(perfluorooctyl)-propyl-1-maleimide tag are
described in Chapters 4, 5 and 6. It is shown that initiators such as perfuorinated siloxanes
trapped within the nanostructured surface of the NIMS chip not only increase the
ionization efficiency of MS based on DIOS, but also exhibit an ability to attach the
immobilized ligands by fluorous phase interactions. This differs significantly from the
immobilization methods above where chemical modifications of the chip surface were
required before adding an affinity tag.
Specifically, the NIMS chip developed in this thesis was used to enrich a subset of
peptides containing cysteine residues from a mixture. Similarly, a kinase activity assay
for phosphorylation and enzymatic inhibitor screening was optimized. Lastly, the
fluorous-affinity NIMS chips were also used to measure enantiomeric excesses by kinetic
resolution.
The use of visible lasers to drive NIMS and the development of microstructured
tungsten oxide and titanium dioxide substrates for SALDI MS are discussed in Chapter 7.
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The current state of our understanding of the laser desorption/ionization mechanisms of
MALDI, DIOS and NIMS are compared in Chapter 8 while experimental results which
provide insight into SALDI mechanism using porous Si, and microstructured WO3 and
TiO2 can be found in Chapter 9. These experiments suggest under specific conditions a
new ionization mode can occur in SALDI which we name Surface Assisted Multiphoton
Ionization or SAMPI. Conclusions and possible future experiments are suggested in
Chapter 10.

Studies and
applications of
NIMS

Investigation of
the mechanism

Exploiting new
nanostructure surface
and laser source

Development of
functional fluorous
affinity NIMS chip

Enrichment and
separation of a
subset of peptides
from complex
biological sample

Measurement of
enantiomeric excess
by kinetic resolution
Kinase activity assays
for phosphorylation and
enzymatic inhibitor
screening

Fig. 1.7: Flow chart illustrating the goals of this thesis
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Chapter 2: Experimental
2.1: Materials and Chemicals
Materials: Single-side polished p-type (boron-doped) silicon <100> wafers (381
± 25 µm thickness and 76 mm diameter) exhibiting a low-resistivity of <0.005 Ω-cm were
purchased from Silicon Quest International (Santa Clara, CA, USA). The other materials
used in this work include platinum wire, double-sided 3M XYZ-axis electrically
conductive tape (TED PELLA, INC.), 3M TM copper conductive tape, Petri dishes, a
stainless steel positioning lift, a ruler, a pair of tweezers, a diamond–tip scribe, vernier
caliper (series No.530, Mitutoyo Corporation), as well as different 2 m or 5 m long
Ultraviolet (UV)-Visible (Vis) optical fibers (Ocean Optics Inc.) having core diameters of
100 µm and 200 µm.
Chemicals: Table 2.1 lists all chemicals used in this work including their names,
purities, formula, CAS number and manufacturers.
Table 2.1: The list of all chemicals used in this work
Name (purity), formula and CAS No.

Manufacturer

Dalargin (HPLC grade, >98% purity),
C35H51N9O8

Bachem Americas, Inc. (California, USA)

Prednisolone (≥99% purity), C21H28O5,
50-24-8

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Bradykinin acetate (HPLC grade, ≥98%
purity), C50H73N15O11, 5979-11-3

Sigma-Aldrich Chemical Co. (St. Louis, MO)

α-Cyano-4-hydroxycinnamic acid
(CHCA), C10H7NO3, 28166-41-8

Sigma-Aldrich Chemical Co. (St. Louis, MO)
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Methanol, CH4O, 67-56-1

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Ethanol, C2H6O, 64-17-5

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Acetonitrile, C2H3N, 75-05-8

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Sodium chloride, NaCl, 7647-14-5

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Hydrofluoric acid (48% by weight in
water), HF, 7664-39-3

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

N2 (UHP), 7727-37-9

Spectra Gases

1,3-Bis-(heptadecafluoro-1,1,2,2tetrahydrodecyl)tetramethyldisiloxane,
C24H20F34OSi2 (BisF17), 129498-18-6

Gelest (Morrisville, PA)

3-(Perfluorooctyl)-propyl-1-maleimide,
C15H8F17NO2, 852527-40-3

Fluorous Technologies Inc. (Pittsburgh, PA)

A peptide of LRRASLGC (HPLC grade,
≥98% purity, custom synthesis),
C35H67N14O10S

GenScript USA Inc. (Piscataway, NJ)

Bovine serum albumin (BSA)

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Dithiothreitol (DTT), C4H10O2S2, 348312-3

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Ammonium bicarbonate, NH4HCO3,
1066-33-7

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Sequencing-grade modified trypsin

Promega (Madison, WI)

Hydrogen peroxide (30% solution),
H2O2, 7722-84-1

EMD Chemicals Inc. (Gibbstown, NJ)

Trifluoroacetic acid (TFA), C2HF3O, 7605-1

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

28

Sulfuric acid, H2SO4, 7664-93-9

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Acetic acid, C2H4O2, 64-19-7

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Protein kinase A(PKA)

New England Biolabs Ltd.( Pickering,
Ontario)

Tyrosine kinase enzyme (Abl)

New England Biolabs Ltd.( Pickering,
Ontario)

PKA reaction buffer (including 50mM
Tris-HCl, 10mM MgCl2 and pH 7.5 at 25
)

New England Biolabs Ltd.( Pickering,
Ontario)

NEBuffer for Abl (including 50mM TrisHCl, 10mM MgCl2, 1mM EGTA, 2mM
DTT, 0.01% Brij 35 and pH 7.5 at 25 oC)

New England Biolabs Ltd.( Pickering,
Ontario)

Peptide of IYAAPKKKC,
C47H81N12O11S

GenScript USA Inc. (Piscataway, NJ)

Standard phosphorylation peptide,
LRRASpLGC (HPLC grade, ≥98%
purity, custom synthesis)

GenScript USA Inc. (Piscataway, NJ)

C-Methylcalix[4]resorcinarene,
C32H32O8, 65338-98-9

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Calix[4]arene, C28H24O4, 74568-07-3

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Ammonium bicarbonate, NH4HCO3,
1066-33-7

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Imatinib mesylate (a crystalline solid,
purity, ≥98%), C29H31N7O, 152459-95-5

Cayman Chemical (Ann Arbor, MI)

Staurosporine (a solution in ethyl acetate, Cayman Chemical (Ann Arbor, MI)
purity, ≥98%), C28H26N4O3, 62996-74-1
Titanium foil (Ti, 0.1 mm thick, 99.99%
purity), 7440-32-6

Sigma-Aldrich Chemical Co. (St. Louis, MO)
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Tungsten foil (W, 0.127mm thick, 99.9%
purity), 7440-33-7

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Caffeine, C8H10N4O2, 58-08-2

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Fluorouracil, C4H3FN2O2, 51-21-8

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Quinidine, C20H24N2O2, 56-54-2

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Dexamethasone, C22H29FO5, 50-02-2

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Erythromycin, C37H67NO13, 114-07-8

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Silver chloride, AgCl, 7783-90-6

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

(R)-(+)-1-Phenylethanol, 1517-69-7 and
(S)-(-)-1-Phenylethanol, 1445-91-6,
C8H10O

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Fluorous mass-tagged N-acylprolines
(custom synthesis), C20H16F13O3N and
C22H16F17O3N

Fluorous Technologies Inc. (Pittsburgh, PA)

1,3-Dicyclohexylcarbodiimide (DCC),
C13H22N2, 538-75-0

Sigma-Aldrich Chemical Co. (St. Louis, MO)

4-Dimethylaminopyridine (DMAP),
C7H10N2, 1122-58-3

Sigma-Aldrich Chemical Co. (St. Louis, MO)

Dichloromethane, CH2Cl2, 75-09-2

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)

Phosphoric acid, H3PO4, 7664-38-2

Caledon Laboratories Ltd. (Georgetown,
Ont., Canada)
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2.2: Instrumentation
The following section is a description of the major pieces of equipment used in
this thesis.
2.2.1: The set-up for preparation of pSi
A home-made silicon wafer etching cell was built for this work which was
composed of two circular Teflon sections, as shown in the Fig. 2.1; a bottom piece and a
top piece sealed by an O-ring and held together by screws. The anode, connected to the
silicon wafer using conductive copper tape attached to its backside, provided electrical
contact as a working electrode, while a platinum wire acting as the cathode was
positioned within the cell cavity as a counter electrode.
In galvanostatic mode, a VersaSTAT 3 potentiometer operating off the V3-Studio
software package controlled the current between the counter and working electrodes at a
specified voltage; specifically, the potential applied to the counter electrode was set to
establish the desired cell current.
2.2.2: Mass spectrometer
In general, any mass spectrometer designed for MALDI MS can be used for
NIMS without further modification. In this work, an Applied Biosystems/MDS Sciex
API-365 LC/MS/MS triple quadrupole (QqQ) electrospray ionization (ESI) MS
reconfigured with a home-made MALDI ion source, was provided as an in-kind
contribution to this research project by MDS Analytical Technologies. As shown in Fig.
2.2, NIMS chips were attached to the face of a home-made MALDI target plate using
electrically conductive double-sided tape. The triple QqQ-MS was maintained at a
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a

b

Fig. 2.1: The Teflon cell assembly used for etching Si wafers electrochemically. a)
The silicon wafer or chip is placed with its polished side facing the O-ring. A
section of conductive copper tape is attached on its backside with a section
sticking outside of the assembly; b) The Teflon base is attached to the top half of
the assembly with the chip sandwiched between; c) The positive (+) (red)
electrode is attached to the silicon wafer chip by clipping a lead to the conductive
copper foil while the negative (-) (black) electrode was attached to a platinum
wire.

c
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pressure less than ~10-5 Torr by two turbo pumps connected in parallel and backed by a
mechanical pump.
UV pulses from a N2 laser were directed to the sample plate via an optical fiber
and focused to a spot on the NIMS chip surface with an f =10 cm focal length lens. N2 gas
(0.1 Torr, UHP) was introduced into the ionization region of the spectrometer to cool the
ions and improve the ion focusing. The laser pulse energy was adjusted with a variable
beam attenuator, and the laser intensity at the output of the optical fiber was measured
with a NOVA Laser Power/Energy Monitor (OPHIR). The resultant ions were mass
dispersed within the triple quadrupole and detected using a channeltron electron
multiplier (CEM, Burle Industries).

Fig. 2.2: A schematic of the experimental apparatus used to perform NIMS.
The SEM image (lower right) of the pSi substrate shows the typical
morphology of the NIMS chip surfaces used in this work (lower left).
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2.2.3: Laser equipment
Nitrogen laser: In this work, two N2 lasers having an output of 4 ns long pulses at
wavelength λ = 337 nm were operated at a repetition rate of 10 Hz. One was
manufactured by Thermo Laser Science (model VSL-337ND-S) while the other was
made by Laser Science, Inc. (LSI). They both use a replaceable and sealed laser cartridge
which includes the laser cavity, high voltage storage capacitors, a switching element, and
can be triggered internally or externally. A variable optical power attenuator (Mitutoyo)
was mounted on the output side of the N2 laser, allowing the laser energy to be manually
changed and precisely controlled.
Neodymium: Yttrium Aluminum Garnet (Nd:YAG ) laser operating at 355
nm: 4 ns infrared (IR) laser pulses at λ =1064 nm were generated at a repetition rate of 20
Hz using a Q-switched Nd:YAG laser (Spectra Physics, PRO 250). The IR output was
frequency-doubled to 532 nm in a nonlinear potassium dideuterium phosphate (KDP)
crystal. The resultant 532 nm output was then frequency-mixed with the residual 1064 nm
fundamental to produce UV light at 355 nm. The UV output was subsequently used for
the MS experiments described in this thesis.
In general, the Spectra Physics Nd:YAG laser uses an injection seeder (Spectra
Physics Model 6350) to achieve single mode operation by injecting very narrow line
width radiation into the laser cavity at a time when the Q-switch is opened. In a Qswitched laser, energy is stored in the laser medium during flash-lamp pumping by
ensuring the quality (Q) factor of the cavity is low. That energy is then released rapidly in
a single, short burst by switching the Q-factor of the cavity to a high value. Specifically,
in the Spectra Physics device during operation the flash lamp excites the Nd3+ ions in the
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YAG rods for ~ 200 µs, building up a large population inversion. When a high voltage
pulse is applied to an opto-electronic Q-switch (Pockel cell), the threshold gain in the
cavity is reduced. This results in a giant pulse of light (duration < 10 ns) with a peak
optical power of tens of megawatts in the infrared (λ = 1064 nm). During seeded
operation, a narrow line width laser emission from a diode laser is injected on-axis into
the Nd:YAG laser cavity which is resonantly amplified by the flash-lamp/Q-switch
assembly. As a result a Q-switched pulse of the seed emission builds up. Seeding
prepopulates one specific longitudinal mode with photons, giving this mode an advantage
of being amplified more rapidly and finally becoming the dominant output signal. The
output of an injection seeded Nd:YAG laser is highly monochromatic, and consequently,
has a long coherence length [74].
Nd:YAG laser operating at 532 nm: Coherent radiation at 532 nm was
generated by frequency doubling the output of a Q-switched Nd: YAG laser (Quanta-Ray
GCR-4; λ = 1064 nm) in a KDP nonlinear crystal. The 532 nm laser beam operating at a
10Hz repetition rate was introduced into a 100 µm diameter optical fiber using a 5 cm
focal length lens and directed towards the sample plate of the mass spectrometer. The
laser intensity at the output of the optical fiber was regulated by a half-wave plate and
polarizer combination, and measured with a laser power meter. This particular Nd:YAG
laser is not injection seeded.
2.2.4: Other pieces of equipment
The VersaSTAT 3: The VersaSTAT 3 (Princeton Applied Research; Oak Ridge,
TN) is a simple, flexible, and extremely powerful system for performing a wide range of
electrochemical measurements. It can serve as either a potentiostat or galvanostat, and if
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desired, a frequency response analyzer (FRA). The unit can be controlled by the V3Studio electrochemistry software package using any PC equipped with a suitable
Universal Serial Bus (USB) interface.
Scanning electron microscopy (SEM): Scanning electron microscopy (SEM)
images were obtained using the LEO-ZEISS 1540XB CrossBeam instrument located in
the Nanofabrication Laboratory in the Department of Physics and Astronomy of the
University of Western Ontario. The instrument has a high resolution Fast Ion Beam (FIB)
for precision milling, and can provide a high resolution images that allow fabricated
nanostructures to be inspected in real time.
Digital pulse generator: A digital pulse generator (Stanford Systems Research
Inc; Model DG535) was used to trigger the oscilloscope, the N2 laser and the Nd:YAG
laser, and synchronize the different optical and mechanical components of the apparatus
used in two-laser system.
2.3: Experimental methods
2.3.1: Preparation of a fluorous-affinity NIMS chip
NIMS chips are not commercially available. The preparation of a fluorous-affinity
NIMS chip involves a series of steps such as pre-etching treatment, assembling the Teflon
cell, handling it after etching, loading initiators and immobilizing fluorous affinity tags.
The details are as follows:
Treatment before etching:


Silicon chips of an appropriate size are cut from a Si wafer using a diamond tip
scribe and a ruler prior to insertion into the etching chamber.
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The cut wafers are soaked in glass Petri dishes containing Piranha solution for 60
minutes. A Piranha solution is composed of concentrated sulfuric acid and
hydrogen peroxide in a fixed volume ratio of H2SO4:H2O2 = 2:1. In general, it
was found that the cleaning is more effective using freshly prepared Piranha
solution for each use presumably because concentrated sulfuric acid and
hydrogen peroxide easily evaporate, changing the volume ratio with time and
thereby decreasing the oxidation effectiveness of the solution.



After cleaning, the silicon chips are removed from the Petri dish using stainless
steel tweezers, rinsed immediately with deionized water, and blown dried rapidly
by a jet of UHP N2. The process is repeated approximately 3~5 times. It should
be noted that methanol and other organic solvents cannot be used to rinse the
just-soaked wafers, since the mixing of Piranha solution with organic solvents
may cause a fire or an explosion.



All experimental components (Teflon lid and base, electrodes, platinum wire,
tweezers, etc) are cleaned in methanol for 15 minutes using an ultrasonic cleaner.
Steps for assembling the Teflon cell, and for electrochemical etching:



An O-ring is placed into the groove of the Teflon lid.



The silicon chip is placed with its polished side facing the O-ring. A section of
conductive copper tape is attached in the other side of the chip with part of the
copper tape sticking outside of the assembly.



The Teflon base is joined with the top half of the assembly with the Si chip
sandwiched between.

37



The assembly is secured with screw caps.



The assembly is leak tested by placing some methanol in the chamber. The
methanol is poured out if the seal is good, and the assembly blown dry with UHP
nitrogen.



The assembly is placed in a Petri dish on a stainless steel lift, and positioned to
ensure that the platinum wire is centered in the middle of the cell.



The positive (+) electrode is attached directly to the conductive copper tape
while the negative (-) electrode made from a platinum wire is mounted onto a
support stand.



The stainless steel base is lifted so that the platinum wire first makes contact with
the top of the chip inside the chamber. The base is then lowered to ensure that
the distance (~1 cm) between the platinum wire and silicon surface is the same
for each experiment.



An etching solution composed of a mixture of HF and ethanol is carefully added
to the cell to just cover the platinum wire and chip.



The electrochemical etching is processed in galvanostatic mode using the
VersaSTAT 3 system for 30 minutes operating at a constant current of 96 mA.
This corresponds to a current density of 45 mA/cm2.
After etching:



Both electrodes are removed from the etching cell and washed to remove any
excess HF/ethanol solvent. This is especially important for the platinum
electrode because it is in direct contact with the HF/ethanol solvent. Prolonged
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exposure causes corrosion and contamination.


The HF/ethanol solution is carefully poured out of the assembly into a plastic
beaker. The assembly is subsequently thoroughly washed with methanol.



The Teflon cell is dried under UHP nitrogen and then disassembled by reversing
the assembly procedure provided above.



The chip is carefully removed with a pair of tweezers and washed with methanol
to remove any excess HF/ethanol solution. The chip is then dried under UHP
nitrogen. This step is repeated ~3-4 times.



Lastly, the chip is baked in an oven (Fisher Scientific) at 120°C for ~5 minutes.
Loading the initiators



~ 2 µL of an initiator molecule such as BisF17 is spotted to cover the pSi chip
surface and kept in a Petri dish for approximately 30-60 minutes at room
temperature.



Excess initiator is blown off from the chip surface using a strong jet of UHP N2
gas until a thin film of initiator is left covering the pSi chip.



The resultant NIMS chip is briefly placed in a 100 0C oven for 3-5 seconds, and
then placed under a UHP N2 again to blow off the excess initiator. These steps
are repeated about 3-5 times until the chip surface partially dry. Drying the chip
completely and leaving too much initiator on its surface impacts the NIMS
performance.
Immobilizing the fluorous affinity tag:
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A 1 mM stock solution is prepared by adding 55.7 mg of 3-(perfluoroalkyl)
propyl-1-maleimide (C15H8F17NO2, RF17) into 100 mL methanol solvent, and
then diluting to 10 μM using neat methanol solvent.



1 μL of such solution (10 μM) is spotted onto the NIMS chip. The fluoroustagged molecules with a maleimide-functionalized group are held to the chip by
non-covalent fluorine-fluorine interactions between the fluorous tag and the
perfluorous initiator molecules trapped within the nanostructured surface.

2.3.2: NIMS MS experimental procedure
The surface of each NIMS chip, anchored to a sample probe using electricallyconducting double-sided carbon tape, were spotted with analyte using a pipette (Fig.2.3),
and then placed inside the home-build MALDI mass spectrometer. The chips could be
irradiated with the output of a pulsed N2 laser (λ = 337 nm), Nd:YAG laser (λ = 355 nm)
or Nd:YAG laser (λ = 532 nm), operating at a 10 Hz repetition rate. In general, the total
volume used per spotting was 1 μL (unless stated otherwise) and the NIMS analysis was
performed by scanning the Q1 quadrupole in positive ion mode. The optimal voltage and
gas pressure settings used for operating the triple quadruple mass spectrometer are listed
in Table 2.2.
Typically, each mass spectrum is acquired using ~1000 laser shots, each pulse
having 5 μJ of energy. Spectra were collected from at least 5 different positions on the
NIMS chip. The peak intensity of a specific mass peak is reported after normalizing to the
intensity of the strongest feature in the spectrum.
Collision-induced dissociation (CID) spectra of certain species could also be
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Fig. 2.3: The photo on the left shows a NIMS chip mounted onto the face of
an in-house modified MALDI target plate with double-sided adhesive tape.
The photo on the right shows the NIMS chip being spotted with analyte
solution using a pipette.

Table 2.2: Mass spectrometer operating settings for NIMS experiments in
positive ion mode
Nebulizer gas pressure (NEB)

1 mTorr

Curtain gas pressure (CUR)

3 mTorr

Collision gas pressure (CAD)

0

Orifice ring voltage (OR)

5.0 V

Quadrupole 2 rod offset voltage (RO2)

-25.0 V

Focusing ring voltage (RNG)

0.0 V

Quadrupole 0 rod offset voltage (Q0)

-6.00 V

Inter-quad 3 lens voltage (IQ3)

-26.5 V

Quadrupole 3 rod offset voltage (RO3)

-27 V

Deflector voltage (DF)

-400.0 V

Channeltron electron multiplier voltage (CEM)

1800.0 V
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recorded for MS/MS analysis, for example, a peptide containing a cysteine residue with a
relatively intense peak in the mass spectrum, selected from a BSA digest. Operationally, a
selected ion is accelerated to a kinetic energy by a potential difference of 30 V between
Q0 and Q2 (Fig. 2.2). The collision gas (N2) pressure of approximately 2.0 × 10-3 Torr
was then used to obtain the product spectrum of the selected precursor ion, [A+H]+ over a
mass range of m/z 100-1500.
2.3.3: Enrichment of cysteine-containing peptides
A NIMS chip spotted with a fluorous affinity tag was dosed by aliquots of a
peptide mixture containing Pep1 (YAGFLR; 200 fmol), Pep2 (LRRASLGC; 200 fmol)
and Pep3 (RPPGFSPFR; 200 fmol), dissolved in a 70 % acetonitrile water solution by
volume with 1% Dithiothreitol (DTT). The substrates were kept in a humidified 6-liter
water bath chamber at 60 0C for 60 min, washed with 40% methanol and water solution
with 0.1% Trifluoroacetic acid (TFA) 3-5 times and then dried under a stream of UHP
nitrogen. Note, the capital letters labeling the peptides correspond to the standard 1-letter
codes used for amino acid residues in a protein. The abbreviations for the 20 common
amino acids are listed in Table 2.3.
A tryptic digestion of BSA was performed by denaturing 1 mg of sample in 1 mL
of boiling distilled water for 60 minutes. 1 mL of 2 mM DTT was then added to the BSA
solution and maintained at 60 0C for 30 minutes to cleave any disulfide bonds. After
cooling to room temperature, 20 μg of sequencing-grade trypsin was added to the BSA
solution with a final protease: protein ratio of 1:50. The reaction mixture was then
incubated at 37 0C overnight. The digest was quenched by the addition of 10 μL of acetic
acid. Subsequently, 1 µL of the BSA tryptic digestion was spotted onto the fluorous-
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affinity NIMS chip to enrich the subset of peptides containing cysteine residues according
to the aforementioned method.
Table 2.3: Abbreviations used for amino acids
Amino Acid

Three-Letter Abbreviation One-Letter Abbreviation

Alanine

Ala

A

Arginine

Arg

R

Asparagine

Asn

N

Cysteine

Cys

C

Glutamate

Glu

E

Glutamine

Gln

Q

Glycine

Gly

G

Histidine

His

H

Isoleucine

Ile

I

Leucine

Leu

L

Lysine

Lys

K

Methionine

Met

M

Phenylalanine

Phe

F

Proline

Pro

P

Serine

Ser

S

Threonine

Thr

T

Tryptophan

Trp

W

Tyrosine

Tyr

Y

Valine

Val

V
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2.3.4: Enzyme activity assay
A substrate (Pep2; 200 fmol) for protein kinase A (PKA) was spotted onto a
NIMS chip with the fluorous affinity tag prepared as described above, and then treated
with 1μL of enzyme solution. Protein kinase assays were performed according to the
manufacturer’s protocol for PKA. In brief, reaction mixtures containing 200 μM ATP, 10
mM MgCl2, and 1 unit/μL PKA in Tris-HCl buffer (pH 7.5) were added to a substrate of
the enzyme in a humid chamber at 30 0C for 30 min. The chip surface was then rinsed
using 40% methanol water solution and analyzed by NIMS.
For an enzymatic inhibition assay, the inhibitor of staurosporine or imatinib was
added to an enzyme reaction mixture and prepared in a series of concentrations using
PKA reaction buffer or NEBuffer, respectively. 1μL of each reaction mixture was spotted
onto the NIMS chip and incubated at 30 oC for 30 minutes. After the kinase reaction, the
chip was rinsed and analyzed according the procedure described above.
2.3.5: Measurement of enantiomeric excess by kinetic resolution and NIMS
A solution of 1-phenylethanol (10 nmol in 1 µL of CH2Cl2) was placed on a pSi
NIMS substrate covered with BisF17 initiator. A mixture of (R)-N-acylproline (100 nmol)
with a (-C6F13) fluorous tag and (S)-N-acylproline (100 nmol) with a (-C8F17) fluorous tag
in 10 µL of CH2Cl2 was then added, followed by 5 µL of a mixture of 4dimethylaminopyridine (DMAP, 100 nmol) and 1,3-Dicyclohexyl- carbodiimide (DCC,
10 µmol). NIMS analyses were performed after evaporating the CH2Cl2 solvent at room
temperature.
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2.3.6: Methodology to fabricate WO3 and TiO2 substrates
WO3 substrates for NIMS were prepared using 0.127 mm thick tungsten foil
(99.9% purity). A microstructured surface was generated by irradiating the W foil with
the 355 nm output of a tripled Nd:YAG laser (Spectra Physics PRO-250; 4 nsec pulses;
20 Hz repetition rate) for 40 minutes in methanol solvent (intensity = 4–5 W/cm2 ), as
shown in Fig.2.4. The resultant WO3 substrate was subsequently rinsed with methanol
solvent three times, and dried under a nitrogen gas flow for 15 minutes. The resultant
WO3 substrates were activated by heating in an oven for 4 hours at 275 °C. Each WO3
substrate could be reused an indefinite number of times. Between runs, a substrate was
soaked in methanol solvent for different periods of time depending on the previous
analyte concentration prior to re-spotting with analyte. Heat reactivation was only
necessary in those instances when the surface becomes damaged due to the use of high
incident laser fluencies [75].
Nd:YAG laser (λ=355nm)

Fig.2.4: Schematic diagram of the experimental arrangement used
to fabricate a microstructured WO3 NIMS chip by laser irradiation.
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TiO2 chips were made by sonicating pieces of titanium cut from a large foil in
isopropanol, ethanol, and deionized water, respectively, and then dried under a nitrogen
gas flow. The samples were then immersed into a 1M H3PO4 containing 0.5 wt% HF acid
electrolyte solution inside the electrochemical cell described previously in Section 2.2.1.
Pt and Ti sheets served as the cathode and anode, respectively. Electrochemical etching
was carried out using a potentiostat (VersaSTAT 3, Princeton Applied Research)
interfaced to a computer. A potential was ramped from 0 V to 10 V at a sweep rate of 500
mV/s, and then held at 10 V for 500 seconds. After electrochemical treatment, the
samples were rinsed thoroughly with deionized water and dried in a nitrogen stream. The
resultant microstructured chips were baked in an oven for 20 minutes at 120 ºC.
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Chapter 3: Optimization and characterization of NIMS
3.1: Optimized conditions for preparing NIMS chip
NIMS sample plates were made by etching a silicon wafer electrochemically in
HF/ethanol solution as described in Chapter 2. The resultant matrix-free NIMS substrate
can be made reproducibly and are robust, exhibiting a broader analyte mass range and
higher analyte ion yield [30]. As NIMS substrates are not commercially available, users
must fabricate and characterize their own. It is well-known that different parameters such
as the silicon crystal orientation, light intensity, dopant type and level, current density,
etching solution concentration, and etching time are able to affect the pSi morphology
[76, 77]. In general, the resultant pore diameter for n-type (P-, As-, or Sb-doped) silicon
increases with increasing resistivity (decreasing density of dopant atoms), while the
reverse is true for p-type (boron-doped) samples. Pore depth is generally proportional to
etching time for both n- and p-type materials [78]. Furthermore, a clean silicon wafer
surface is essential since the pSi chips produced using silicon wafers which have not been
cleaned properly before electrochemical etching leads to a background in the low-mass
region of the NIMS mass spectrum [31].
In this work p-type <100> silicon wafers doped with boron were used. The main
etching parameters (etching time, current density, and HF concentration), respectively,
were varied to optimize the pSi sample pore size, and to maximize the signal-to-noise
(S/N) ratio of the NIMS spectra. A hexapeptide Dalargin (YAGFLR) was selected as an
analyte to test the NIMS performance. Dalargin is a synthetic analog of the
neurotransmitter, Leu-enkephalin consisting of six amino acids. As shown in Fig. 3.1, its
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primary structure is Tyr-Ala-Gly-Phe-Leu-Arg. Dalargin has been implicated in various
biological activities such as cytoprotection, cardioprotection, and anti-stress activity, and
has therapeutic action during alcohol withdrawal [79]. The following discussion describes
these experiments.

Fig.3.1: The chemical structure of the hexapeptide Dalargin

3.1.1: Effect of etching time on the NIMS performance
The effect of etching time on the fabrication procedure on pSi was studied by
detecting the peptide Dalargin by NIMS in positive ion mode. The etching time was
changed from 10 to 35 minutes at 5-minute intervals. The other etching parameters
including current density and hydrofluoric acid/ethanol solution concentration were fixed
to 45 mA/cm2 and 50% (volume ratio), respectively. As shown in the Fig. 3.2, the optimal
etching time was found to be 30 minutes. At times < 30 min the analyte ion intensities
and signal-to-noise (S/N) ratios were lower while at etching times > 30 min the pSi chip
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was found to be more susceptible to breaking. Fig. 3.3 shows two deep grooves that
formed in the pSi chip after etching for 35 min. At these longer times the pSi chip would
simply collapse due to these structural defects. Fig. 3.4 shows the NIMS spectra of
Dalargin obtained for various etching times ≤ 30 min.

Fig. 3.2: A plot of the NIMS Dalargin ion signal as a function of
pSi chip etching time.

Fig. 3.3: A SEM image of pSi chip produced by electrochemical
etching for 35 min at a current density = 45mA/cm2 and using 50%
(by volume) hydrofluoric acid ethanol solution.
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[Dalargin+H]+
10min

20min

30min

Fig. 3.4: NIMS spectra of protonated Dalargin as a function of pSi
etching time using BisF17 as initiator.

50

3.1.2: Effect of current density on the NIMS performance
The pSi fabrication and NIMS signals were examined after processing the Si
wafer using current densities of 10, 20, 30, 35, 40, 45, 50 mA/cm2, respectively, (Fig.
3.5). It should be stressed that the current density at the Si/electrolyte interface has more
physical meaning than the absolute current alone. In this study, both the current density
and the current for a given cell scale similarly because the area of the Si sample exposed
to the electrolyte (1.8 cm2) is well defined. pSi formation is dependent on the current
density at the Si side of the Si/electrolyte interface which forms holes that move from the
bulk towards the interface. However, an overpotential can lead to electropolishing where
a surface film is peeled from Si wafer resulting in a morphology that is relatively smooth
and planar despite the electrical treatment [80]. The upper picture in Fig.3.6 is a
photograph of pSi formed at low potential while the bottom picture shows the smooth Si
surface after electropolishing at a high potential. To form pSi, the potential must be
controlled between 0 V and an overpotential threshold voltage in the electrochemical
etching process. Fig. 3.7 shows that the NIMS signal of protonated Dalargin is strongest
when the current density = 45mA/cm2 with the other parameters fixed (etching time = 30
min and HF acid:ethanol volume ratio = 1:1).
3.1.3: Effect of etching solution and pre-etching cleaning on the NIMS performance
In these experiments the etching solution used was usually a 1:1 mixture by
volume of HF acid and absolute ethanol. As shown in the Figs. 3.8 and 3.9 substantial
deviations from these “optimum” etching conditions could be tolerated without a
significant loss in performance.
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Fig. 3.5: A plot of protonated Dalargin NIMS signal as a function
of current density.
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Fig. 3.6: The appearances of pSi etched at a normal electrical
potential (< 2.0V; upper picture) and after electropolishing at an
overpotential (> 2.0 V; lower picture).
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[Dalargin+H]+

30mA/cm2

40mA/cm2

45mA/cm2

Fig. 3.7: NIMS spectra of protonated Dalargin as a function of
current density using BisF17 as initiator.
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A clean silicon surface before electrochemical etching is crucial for obtaining high
quality NIMS mass spectra with good S/N ratios. That was demonstrated in this work by
comparing NIMS mass spectra of protonated Dalargin using a pSi chip prepared with and
without Piranha solution cleaning before electrochemical etching. Fig.3.10 shows that a
clean NIMS chip yields a mass spectrum with substantially lower background noise in the
low molecular weight mass region than one produced without cleaning. Table 3.1
summarizes the critical parameters and their optimal values deduced in this study for
preparing pSi.

Fig. 3.8: The NIMS ion intensity (ion counts) of protonated Dalargin as
a function of the etching solution volume ratio.
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[Dalargin+H]+

VHF/VEtOH = 0.5

VHF/VEtOH = 1

VHF/VEtOH = 2

Fig. 3.9: NIMS spectra obtained from pSi substrates formed
using different etching solution volume ratios.
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[Dalargin+H]+
a)

b)

Fig. 3.10: Comparison of the NIMS spectra of Dalargin using
pSi prepared with and without Piranha solution cleaning before
electrochemical etching. a) NIMS spectrum of Dalargin obtained
using a chip that was not cleaned with Piranha solution; b)
NIMS spectrum of Dalargin obtained with a chip that was
cleaned with Piranha solution. BisF17 was used as the initiator in
both experiments.
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Table 3.1: Critical parameters and their optimum values for making pSi
Parameter

Optimum value

HF acid concentration (volume percent)

50

Unit
% by volume

Current density

45

mA/cm2

Etching time

30

min

Wafer resistivity (p-type)

<0.005

Ω-cm

Pre-etching cleaning with Piranha
2:1

Ratio by volume

solution (98% H2SO4/30%H2O2)
Potential

<2.0

V

3.2: Characterization of NIMS
3.2.1: SEM imaging of the NIMS chips
As shown in the upper image of Fig.3.5 pSi is visually black. The SEM image in
Fig. 3.11 shows that the pSi surface is composed of 10~20 nm pores which can be filled
with an initiator.
3.2.2: Comparison of MALDI, DIOS and NIMS
In this work, the peptide Dalargin was used as an analyte to test the sensitivity of
NIMS and to compare the quality of the mass spectra obtained by NIMS, DIOS and
MALDI MS.
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Fig. 3.11: SEM image of the nanostructured surface of a pSi chip obtained using the
experimental conditions listed in the Table 3.1.

The [Dalargin+H]+ peak maximum at m/z 726.5 was used to determine the LOD
for NIMS. The noise in a S/N evaluation was determined by measuring the average value
of the pure noise level between m/z 723 and 725 over ~1000 laser shots, each pulse
having 5 μJ of energy. The average S/N values obtain reflect both the instrumental noise
and chemical noise due to the residual contamination on the NIMS surface. The amount
of Dalargin in the each spot irradiated by the laser beam was calculated based on the ratio
of the laser spot area to the whole sample surface area of the NIMS chip. The laser was
repositioned at different locations on the NIMS chip 5 times, and each run at a specific
location was repeated 5 times. The resultant ion intensities were then averaged. A S/N
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ratio = 3 was considered the minimum value that would allow a peak signal to be clearly
differentiated from the noise, thereby giving an indication of the lowest concentration that
could be measured reliably.
A standard curve made by plotting the S/N of the NIMS Dalargin ion intensity
against number of moles of Dalargin in the spot is shown in Fig. 3.12. A linear regression
of the data yielded a R2 value of 0.9941 and a LOD of (0.64  0.03) fmol. This constitutes
an improvement of ~2000 x in the Dalargin LOD over the value obtained with the same
mass spectrometer by DIOS (0.32  0.04 pmol [83]). It can be concluded that compared
to DIOS, NIMS yields spectra with a higher S/N ratio and is a more sensitive analysis
technique.

Fig. 3.12: A plot of the S/N ratio of the Dalargin NIMS ion signal versus the
number of moles of Dalargin in the sample of the irradiated laser spot.
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The NIMS spectrum of Dalargin was compared to that obtained by MALDI MS.
CHCA was used as the matrix for the latter technique and the mass spectrum was
recorded using the same quadrupole mass spectrometer in positive ion mode. As shown in
Fig. 3.13, the NIMS spectrum exhibits strong analyte signals with low background noise.
Conversely, there are comparatively more fragment and matrix-related peaks in the
MALDI mass spectrum. This confirms that matrix interferences in MALDI MS represent
a real limitation that is absent for NIMS.
3.2.3: The effect of sample storage time
The effect of keeping a pSi chip in storage for different lengths of time prior to
use for DIOS or NIMS was evaluated by keeping some samples in clean, closed glass
containers under one atmosphere at room temperature for 30, 90 and 180 days,
respectively. Each pSi surfaces was subsequently dosed with 1µL of 10 µM of Dalargin
solution before each DIOS or NIMS (initiator, BisF17) measurement, and probed with a
N2 laser (337 nm) having 5µJ energy per pulse.
The ion intensity in the NIMS spectra changed very little when using a freshly
prepared pSi chip or one that was stored for 180 days (Fig.3.14). This shows that keeping
a pSi chip in air for months does not significantly influence the NIMS performance. In
contrast, the DIOS performance of a pSi chip stored in air for 180 days was very much
degraded relative to a freshly made sample. Figs. 3.15 and 3.16 show the NIMS and
DIOS spectra obtained from pSi chips stored in air for 0 (freshly prepared), 30 and 180
days, respectively.
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a)
[Dalargin+H]+

b)

c)

Fig. 3.13: a) MALDI mass spectrum of Dalargin using a CHCA
matrix (1µL, 1mM); b) DIOS mass spectrum of Dalargin; c) NIMS
spectrum of Dalargin using BisF17 as initiator. Each sample
contained the same amount of Dalargin (1µL, 10µM). The same
laser energy per pulse (5µJ) was used in each experiments and the
mass spectrometer was scanned over the same mass range of 100800 amu.
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One probable reason why the DIOS performance becomes worse after a pSi chip
has been stored for a long time in air is that pSi surface groups can become oxidized to
silicon oxide (Si–O–Si) and silicon hydroxide (Si–OH) moieties which can dramatically
change the surface wetting properties from hydrophobic to hydrophilic. When the surface
is hydrophilic the sample droplet is not effectively confined to the porous area [15]. In
general, DIOS performance degrades with increasing surface oxidation. Still, it has been
noted that some hydrophilic compounds can be detected with better sensitivity using
lightly oxidized surfaces or surfaces derivatized with polar functional groups [82]. For
NIMS, however, the pSi chip surface is covered with a thin film of fluorous-phase
initiator which effectively confines the sample droplet due to its immiscibility with both
aqueous and organic phases [83]. Oxidation of surface groups under these conditions
therefore has less of an influence on the NIMS performance.

Fig. 3.14: Protonated Dalargin signal intensities obtained by NIMS
(initiator, BisF17) and DIOS as a function of pSi storage time in air.
Note that 0 days implies a freshly prepared pSi chip.
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[Dalargin+H]+
0 days

30 days

180 days

Fig. 3.15: NIMS spectra of Dalargin as a function of storage time
in air. Note that 0 days indicates a freshly prepared pSi chip.
BisF17 served as the initiator for each run.
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[Dalargin+H]+
0 days

30 days

180 days

Fig. 3.16: DIOS mass spectra of Dalargin as a function of storage
time in air. Note that 0 days indicates a freshly prepared pSi chip.
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3.3: Analyses of small molecule drugs and peptides using NIMS
Since its introduction in 1980s, MALDI MS has been extensively used to analyze
large molecules such as synthetic polymers [84], proteins [1], carbohydrates [85] and
nucleic acids [86]. However, its utility is greatly limited in the analysis of small
molecules due to background signal interferences from the organic matrix or fragments
which can overlap those of the analyte in the mass spectra [87]. NIMS extends the
observable mass range to small molecules [30] because these interferences are no longer a
factor. The analysis of small molecules such as drugs, metabolites and other biologically
important species is therefore one of the potential strengths of this technique. Analyses
can be carried out by detecting analytes as radical cations, as protonated ions or as cation
adducts depending on the specific compound.
In this section, it is demonstrated that NIMS can be used to detect small molecules
that undergo different ionization modes. Five low and moderate molecular weight
analytes were selected: the pharmaceutical compounds Fluorouracil (molecular weight,
MW = 130 amu) and Quinidine (MW = 324 amu) which ionize to form radical cations;
the peptide Bradykinin (MW = 1060 amu) which is readily detected as a protonated
species, and the steroid Dexamethasone (MW = 392 amu) and sugar-containing drug
Erythromycin (MW = 734 amu) which can be detected as metal cation adducts.
3.3.1: NIMS spectra of molecules that form radical cations
Fluorouracil (or 5-FU, Fig. 3.17) is a chemotherapy agent widely used in the
treatment of a range of cancers including colorectal and breast cancers [88]. An aliquot
part of 5-FU (2 μl, 0.1 μM) was spotted directly onto the pSi surface coated with BisF17
initiator and allowed to dry before NIMS analysis. The mass spectrum in Fig. 3.18 was
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Fig. 3.17: The chemical structure of Fluorouracil

obtained by positioning the focus of the N2 laser (337 nm; 10 μJ/pulse) a distance of 0.4
mm above the surface of pSi chip. The dominant feature in the spectrum is the 5-FU’s
radical cation peak [5-FU]+. The rationale for placing the laser focus 0.4 mm above the
substrate surface and a potential mechanism for the generation of radical cations is
discussed in detail in Chapter 9 of this thesis.
The LOD for 5-FU was determined by plotting the S/N ratio associated with the
mass spectral peak intensity of the cation, (m/z 130), versus the number of moles of 5-FU
in the laser spot at the chip surface, which was calculated based on the ratio of the laser
spot area to the whole sample surface area of the NIMS chip (Section 3.2.2). The S/N
ratio was determined by measuring the average value of the noise level between m/z 119
and 129. As shown in Fig. 3.19, a linear regression of the data yields a R2 value of 0.9965
and a LOD of (4.8  1) × 10-16 mol.

67

[5-FU]+

Fig. 3.18: NIMS spectrum of Fluorouracil (200 fmol) obtained by using
BisF17 as the initiator and placing the focus of the N2 laser (337 nm; 10
μJ/pulse) a distance of 0.4 mm above the surface of the pSi chip.

Y = 1.85×1016 X - 5.9
R2 = 0.9965

LOD: (4.8 ± 1) × 10-16 mol

Fig. 3.19: A plot of the S/N ratio of the 5-FU NIMS signal at m/z 130
versus the number of moles of sample within the laser spot.
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Quinidine (Fig. 3.20), a stereoisomer of quinine, is a pharmaceutical agent that
can act as a class I antiarrhythmic agent for the heart [89]. The NIMS spectrum of
Quinidine (m/z 324) using BisF17 as the initiator and positioning the focus of the N2 laser
(337nm, 10μJ/pulse) 0.4 mm (the reason to set up the distance will be discussed in
Chapter 9 in detail) above the surface of the pSi chip is shown in the Fig. 3.21.
The LOD for Quinidine was determined in a manner similar for 5-FU and
described in Section 3.2.2. The S/N ratio was determined by measuring the average value
of the noise level between m/z 318 and 323. As shown in Fig. 3.22, a linear regression of
the data yields a R2 value of 0.9968 and a LOD of (1.0  0.1) × 10-15 mol.

Fig. 3.20: The chemical structure of Quinidine
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[ Quinidine]+

Fig. 3.21: NIMS spectrum of Quinidine (200 fmol) obtained by using
BisF17 as the initiator and placing the focus of the N2 laser (337 nm;
10 μJ/pulse) a distance of 0.4 mm above the surface of the pSi chip.

Y = 3.74×1015 X - 0.83
R2 = 0.9968

LOD: (1.0 ± 0.1) × 10-15 mol

Fig. 3.22: A plot of the S/N ratio of the Quinidine NIMS radical
cation signal at m/z 324 versus the number of moles of sample
with the laser spot.
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3.3.2: NIMS spectra of molecules that form protonated cations
Bradykinin is a nine amino acid peptide (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg)
with the chemical structure shown in Fig. 3.23. It is formed by cleaving the plasma
precursor kininogen with serine proteases known as kininogenases. Bradykinin is known
to mediate inflammatory responses, increase vasodilation that in turn reduces blood
pressure, and to cause smooth muscles to contract [90].
The NIMS spectrum of Bradykinin using BisF17 as the initiator is shown in Fig.
3.24. The base peak in the mass spectrum is protonated Bradykinin because the neutral
peptide has a strongly basic residue, Arg, which has a large proton affinity (251.2
kcal/mol [91]). The LOD for Bradykinin was determined from the plot shown in Fig.
3.25. The S/N ratio was determined by measuring the average value of the noise level
between m/z 1052 and 1057. A linear regression of the data in Fig. 3.25 yields a R2 value
of 0.9969 and a LOD of (7.1  1) × 10-16 mol.

Fig. 3.23: The chemical structure of Bradykinin
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[Bradykinin + H]+

Fig. 3.24: NIMS mass spectrum of Bradykinin (100 fmol)
on a pSi substrate using the BisF17 initiator and a N2 laser
(337 nm) energy of 5 µJ/pulse.

Y = 1.54×1016 X – 7.62
R2 = 0.9969

LOD: (7.1 ± 1) × 10-16 mol

Fig. 3.25: A plot of the S/N ratio of the Bradykinin NIMS signal (m/z
1061) versus the number of moles of sample within the laser spot.
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3.3.3: NIMS spectra of molecules that form cationized adducts
Carbohydrates and steroids are biologically important classes of pharmaceutical
molecules that are difficult to observe by current surface-based MS methods as a result of
their poor ionization efficiencies by protonation [4, 43]. However, as shown here,
Erythromycin (Fig. 3.26; a carbohydrate-containing antibiotic) and Dexamethasone (Fig.
3.27; a steroid drug) can be detected as metal-cationized adducts using NIMS. In general,
carbohydrates readily form sodium adducts (ANa+) [92] while steroids prefer to form
silver adducts (AAg+) [44].
Erythromycin is an antibiotic used to treat certain infections caused by bacteria
and contains a 14-membered lactone ring and two sugars in structure [4]. Given that the
ionization efficiency of Erythromycin is generally higher with Na+ adducts relative to its
protonated form, 5 µL of NaCl solution (1mM) was deposited onto the pSi chip before
adding the BisF17 initiator to provide a source of sodium cations. The NIMS spectrum in
Fig.3.28 obtained by depositing 10pmol of Erythromycin and irradiating with 337 nm N2
laser pulses having 5 µJ of energy is dominated by a signal at m/z 757 which corresponds
to [Erythromycin + Na]+.
The LOD for Erythromycin was determined from Fig.3.29 to be (1.7  0.2) × 10-14
mol. The S/N ratio here was determined by measuring the average value of the noise level
between m/z 745 and 755. The R2 value from the linear regression of the data = 0.9978.
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Fig. 3.26: The chemical structure of Erythromycin

Fig. 3.27: The chemical structure of Dexamethasone.
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[Erythromycin + Na]+

Fig. 3.28: NIMS spectrum of Erythromycin (100 pmol) on a pSi
substrate using the BisF17 initiator and a N2 laser (337 nm) energy
of 5 µJ/pulse.

Y = 1.97×1013 X + 2.66
R2 = 0.9978

LOD: (1.7 ± 0.2) × 10-14 mol

Fig. 3.29: A plot of the S/N ratio of the Erythromycin NIMS signal (m∕z
757) versus the number of moles of sample within the laser spot.
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Dexamethasone is an anti-inflammatory and immunosuppressant steroid drug
[93]. In this work, 5 µL of AgNO3 solution (1mM) was spotted onto the pSi substrate to
provide a source of cations before adding the BisF17 initiator. The NIMS spectrum of
Dexamethasone (100 pmol) in Fig. 3.30 exhibits two major peaks at m/z 499 and 501 due
to [Dexamethasone + Ag]+. The peak intensities well reflect the natural abundance of the
107

Ag and 109Ag isotopes; 51.8% and 48.2%, respectively [92].
The LOD for Dexamethasone was determined to be (7.5  0.6) × 10-14 mol based

on measurement of the [Dexamethasone + 107Ag]+ signal (Fig. 3.30). Here the S/N ratio
was determined by measuring the average value of the noise between m/z 492 and 497.
The linear regression of the data in Fig. 3.31 yields a R2 value of 0.9955.
[Dexamethasone + 107Ag]+

[Dexamethasone + 109Ag]+

Fig. 3.30: NIMS spectrum of Dexamethasone (100 pmol) on a
pSi substrate coated with BisF17 initiator and AgNO3 (5 nmol).
The spectrum was obtained using the output of a N2 laser (337
nm) having an energy of 5 µJ/pulse.
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Y = 1.22×1013 X + 2.09
R2 = 0.9955

LOD: (7.5 ± 0.6) × 10-14 mol

Fig. 3.31: A plot of the S/N ratio of the Dexamethasone NIMS signal
(m∕z 499) versus the number of moles of sample in the laser spot.
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Chapter 4: On-chip enrichment and analysis of peptide
subsets using maleimide-functionalized fluorous affinity
biochip and NIMS
4.1: Background
To date global analyses of biological samples such as blood, protein digests and
cellular metabolite extractions remain a technological challenge due to its complexity in
terms of the number of compounds involved and dynamic range of their concentrations;
for example, the concentrations of proteins in a plasma can vary by ~10 orders of
magnitude [95]. This problem can be solved in part by a “divide and conquer” strategy
where biologically or clinically important information is obtained by isolating, enriching
and analyzing specific subsets of peptides and proteins [96]. Affinity fractionation and
enrichment for the analysis of specific peptide subsets, is based on the specific binding
between an immobilized ligand and the analyte. For example, antibody-antigen affinity
[97] and biotin-avidin pairing[98] have been widely used in such strategies. Chemically, a
thiol resin has been developed for cysteinyl residues [99], lectins for specific glycosylated
species [100], and metal affinity-based fractionation involving iron and gallium for
phosphorylated peptides [101]. Of them, the biotin-avidin system is arguably one of the
most general approaches because it involves using a dual-functional reagent to form a
common affinity capture moiety. Typical applications of the biotin-avidin pairing involve
binding and enriching targeted analytes by reaction with the biotin group followed by
capture of the biotinylated species through affinity interactions using the immobilized
avidin. Although this method is very effective, the high affinity between biotin and avidin
(with a dissociation constant approaching 10-15 M [72]) often make it difficult for target
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analytes to fully elute from the capture resin [102]. In addition, the biotinylated peptide
can complicate the interpretation of MS/MS spectral data [103]. Lastly, these custom
biological reagents are relatively expensive.
Recently a novel separation and enrichment method based on fluorous-affinity
interactions was introduced [104]. This field has grown since the introduction of fluorous
biphasic catalytic techniques [62]. In general, fluorous-affinity tags for separation and
enrichment participate in one of two modes. The first is based on the use of a F-SPE
column which uses perfluoroalkyl chains as bonded phase instead of a resin to facilitate
analyte separation [105]. Here a sample in solution is selectively labeled with a fluorous
tag containing an appropriate functional group and then loaded onto the fluorous solidphase media for separation. The unbound species and contaminants are subsequently
washed away using a suitable organic solution. Finally, the desired bound species are
eluted from the affinity column for MS analysis [106]. This column chromatographybased method, however, is prone to sample loss due to analyte adsorption onto the solid
phase and is susceptible to sample contaminant during transfer to the mass spectrometer.
The second strategy is based on a biochip where the analytes of interest are
captured by a fluorous tag immobilized on a fluorous-silylated surface by fluorinefluorine interactions. This approach should provide a more rapid and sensitive analysis of
targeted species due to on-site enrichment and washing followed by direct MS analysis
[107]. Fluorous-affinity immobilization has been shown to be useful for small molecule
microarrays that can be used to analyze carbohydrates [61] or screen for inhibitors [55].
In this work, a fluorous affinity tag of 3-(perfluorooctyl)-propyl-1-maleimide
(RF17, Fig. 4.1), which combines a long perfluorous carbon chain(-C8F17 ) with a
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chemically active functional alkene group, is used for the first time on a NIMS chip to
enrich peptides containing cysteine residues, and to improve their detection sensitivity by
mass spectrometry. Initiators such as perfluorinated siloxanes trapped in the nanostructure
pores not only greatly increase the desorption efficiency of MS based on the DIOS, but
also exhibit an ability to immobilize fluorous-affinity tags via fluorine-fluorine
interactions.

Fig. 4.1: The chemical structure of fluorous-affinity tag, 3(perfluorooctyl)-propyl-1-maleimide (RF17).

In this work the utility of our methodology is first demonstrated by determining
the optimal binding and washing conditions for a mixture of three peptides, and then by
separating and enriching cysteine-containing peptides from a Bovine Serum Albumin
(BSA) digest. Finally the compatibility of such fluorous tagged peptides with MS/MS
sequencing strategies is evaluated.
4.2: Results and discussions
The ability to isolate and enrich a desired subset of analytes from extremely
complex mixtures is an indispensable tool for any viable methodology designed to totally
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analyze biosamples such as a protein digest, blood or urine. The workflow designed for
the experiments carried out in this work is shown in the Fig. 4.2. As shown in the Fig. 4.3
the fluorous-affinity tag used in this work was synthesized by a simple and highly
selective Michael addition reaction between the thiol and maleimide groups [108].

1

pSi

2

NIMS chip

Fluorous-affinity
NIMS chip

3

4

Laser-NIMS

Capture of targeted
analytes

Fig. 4.2: Schematic diagram for the methodology: 1. a thin film of initiator is coated
in the surface of porous Si produced by electrochemical etching; 2. a fluorous
affinity tag is immobilized on the NIMS chip by fluorine-fluorine interactions; 3. a
specific peptide is captured by the affinity tag; 4. mass analysis by NIMS.
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+
Cysteinyl contained
peptide
Fig. 4.3: The binding chemical reaction occurring between RF17 and Pep2.

Typically, a crude mixture is loaded onto a NIMS chip containing some specific
fluorous affinity tags. The chip is then eluted with a fluorophobic solvent such as 40%
methanol water solution with 0.1% TFA to remove any unbound nonfluorous compounds,
salts and contaminants. The sample was then subjected to NIMS analysis. To demonstrate
the feasibility of this methodology, a mixture of peptides composed of Pep1 (YAGFLR,
Fig. 3.1), Pep2 (LRRASLGC, Fig. 4.4) and Pep3 (RPPGFSPFR, Fig. 3.23), where only
Pep2 contained a cysteine residue, was tested according to the method described above.

Fig. 4.4: The chemical structure of Pep2 (LRRASLGC).
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4.2.1: Characterization of the binding reaction and washing conditions
Prior to selectively enriching the cysteine-containing peptides using a fluorousaffinity NIMS chip, the conditions required for effective binding between the cysteine
residue(-SH) and maleimide functional group (-C=C-) need to be optimized, as well as
the composition of the methanol / water solution for washing off any unbound species. A
plot of log (ion intensity) for Pep2 (Fig. 4.5) versus reaction time was used to estimate the
rate of the binding reaction at room temperature. The graph shows that the reaction
proceeds quickly for ~the first 90 minutes, then slowly thereafter. The reaction is still ongoing after three hours at room temperature. The binding reaction temperature was varied
by keeping the NIMS chip in a water bath chamber maintained at different temperatures.
Fig. 4.6 is a plot of the ion intensities of tagged and untagged Pep2 as a function of
temperature for a fixed reaction time of 60 minutes. Together, these plots show that the
near optimum conditions for immobilizing the tagged analyte is 60

for 60 minutes.

The effect of the percentage concentration of methanol in the washing solution on
enrichment efficiency was also investigated. As shown in the Fig. 4.7, the signal intensity
for unbound Pep3 in the NIMS chip decreased rapidly with increasing % methanol while
that for the Pep2 bound to the NIMS chip did not significantly change. Although Pep3
appeared to be washed off completely when the amount of methanol in solution reached
60%, at that composition Pep2 was also observed to decrease. It was determined that a
40% methanol in water solution with 0.1% TFA was the most effective composition for
separating the two species.
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Fig. 4.5: The effect of reaction time on cysteine residue binding efficiency.
The square and circle dots show the ion intensities produced by NIMS of
Pep2 plus 3-(perfluoroalkyl) propyl-1-maleimide and untagged Pep2,
respectively, with different reaction time.

Fig. 4.6: The effect of temperature on cysteine residue binding efficiency.
The solid and dash lines show the ion intensities produced by NIMS of
Pep2 plus 3-(perfluoroalkyl) propyl-1-maleimide and untagged Pep2,
respectively, with different reaction temperature.
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Fig. 4.7: Optimization of the washing solvent composition for cysteine
residue enrichment on a fluorous-affinity NIMS chip determined by
plotting the ion intensity of the tagged and untagged peptides as a
function of the percentage of methanol used.

4.2.2: Comparison of the NIMS mass spectra without fluorous affinity tags, before
washing and after washing
First, a mixture of three peptides, Pep1 (YAGFLR, m/z 726.5), Pep2
(LRRASLGC, m/z 876.1) and Pep3 (RPPGFSPFR, m/z 1061.2) was analyzed by a NIMS
chip without using the RF17 immobilizing fluorous-affinity tag. As shown in Fig. 4.8a, all
three peptides exhibit strong protonated parent signals in the mass spectrum, regardless of
whether they contain a cysteine residue or not. When the mixture was incubated with the
immobilized fluorous tag at 60

for 60 minutes (Fig. 4.8b) but not washed before

analysis, the protonated peak of Pep2 shifted to m/z 1433.3, which corresponds to the
mass of protonated Pep2 plus RF17. The mass signals for the other two peptides were
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a)

[Pep3+H]+
1061.2
[Pep1+H]+
726.5

[Pep2+H]+
876.1

b)
[Pep2+RF17+H]+
1433.3

[RF17+H]+
558.2

c)

Fig. 4.8a): NIMS spectrum of the mixture Pep1, Pep2 and Pep3; b): NIMS
spectrum of the mixture Pep1, Pep2 and Pep3 which has been incubated
with the fluorous-affinity NIMS chip before washing; c): NIMS spectrum
of the mixture Pep1, Pep2 and Pep3 which has been incubated with the
fluorous-affinity NIMS chip after washing with a 40% methanol water
solution containing TFA.
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unchanged. In addition, a weaker intensity peak corresponding to protonated
immobilizing fluorous tag (protonated 3-(perfluoroalkyl)propyl-1-maleimide, [RF17+H]+,
m/z 558.2) also appears. This demonstrates that the tag only affected the peptide
containing the cysteine residue. Finally, the mixture on the fluorous-affinity NIMS chip
was analyzed after the unbound peptides had been removed from the chip surface using
the optimized washing solution (Fig. 4.8c). Here, the protonated peaks of Pep1 and Pep3
have almost completely disappeared while the protonated peak of Pep 2 plus
immobilizing fluorous-affinity tag remains. This shows that only the cysteine-containing
peptide was selectively captured by the functionalized NIMS chip and therefore,
effectively enriched.
4.2.3: Enrichment of a cysteine-containing peptide residue from a BSA digest
To further demonstrate the effective utility of fluorous-affinity NIMS chips for the
analysis of complex biological samples, a group of peptides from BSA tryptic digest was
fractionated, enriched and subsequently detected by NIMS. BSA contains 35 cysteine
residues and therefore, produces a relatively complex cysteine-containing peptide residue
mixture after reduction of double bond of S=S and tryptic digestion. Table 4.1 shows all
peptide sequences with mass range from 500 to 3000 Da detected by such a fluorousaffinity NIMS biochip before and after washing using 40% methanol water solution with
0.1% TFA.
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Table 4.1: Assignments of peptides from a BSA tryptic digest using
fluorous-affinity NIMS
Position

Peptide sequence

[A+H]+

[A+RF17+H]+

101-105

VASLR

545.3

223-228

CASIQK

649.3

236-241

AWSVAR

689.4

198-204

GACLLPK

701.4

29-34

SEIAHR

712.4

581-587

CCAADDK

725.3

1282.5



483-489

LCVLHEK

841.5

1398.7



161-167

YLYEIAR

927.5

123-130

NECFLSHK

977.5

1534.7

413-420

QNCDQFEK

1011.4

1568.6



499-507

CCTESLVNR

1024.5

1581.7



588-597

EACFAVEGPK

1050.5

1607.7

66-75

LVNELTEFAK

1163.6

300-309

ECCDKPLLEK

1177.6

361-371

HPEYAVSVLLR

1283.7



402-412

HLVDEPQNLIK

1305.7



76-88

TCVADESHAGCEK

1349.5

1986.7(1)



76-88

TCVADESHAGCEK

1349.5

2543.9(2)



375-386

EYEATLEECCAK

1388.6

1945.8



569-580

TVMENFVAFVDK

1399.7



421-433

LGEYGFQNALIVR

1479.8



Before
washing

After
washing


1206.5








1258.6

















1734.8
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387-399

DDPHACYSTVFDK

1497.6

2054.8

139-151

LKPDPNTLCDEFK

1519.7

2076.9

347-359

DAFLGSFLYEYSR

1567.7

267-280

ECCHGDLLECADDR

1578.6

2135.8

184-197

YNGVFQECCQAEDK

1633.7

2190.9

469-482

MPCTEDYLSLILNR

1667.8

2225.0

508-523

RPCFSALTPDETYVPK

1823.9

2381.1



529-544

LFTFHADICTLPDT
EK

1850.9

2408.1



319-336

DAIPENLPPLTADFAE
DK

1956.0

45-65

GLVLIAFSQYLQQCPF
DEHVK

2435.2

















2992.4





Note: (1). There is a phosphorylation group at position 82 (Serine residue, S); (2). There
are two fluorous-labeled cysteine residues (C) in different positions which are separated
by eight other residues.

Assignments were made by matching the masses of the observed residues with
those calculated using the UniPortKB-Swiss-Prot PeptideMass software. Only seven
peptide fragments containing cysteine residues are seen before washing (Fig. 4.9a),
presumably because of signal suppression and background noises due to the presence of
salts [109]. After washing, the number of cysteine-containing peptides increased to 19
from 7, while the other peptides which did not contain cysteine effectively disappeared,
(Fig. 4.9b). At the same time, the background noise significantly decreased to produce a
mass spectrum with a better signal-to-noise ratio. These results confirm that the
enrichment strategy for cysteine containing fragments with a washing step can effectively

89

simplify the resultant mass spectrum of a complex mixture, and increase the detect
sensitivity for a peptide subset of interest.
Interestingly doubly-labeled peptides were seldom observed for peptides with
adjacent cysteines. The sole example observed of a peptide with two fluorous-affinity
tags is TCVADESHAGCEK, where the two cysteines are separated by other eight
residues. This is different from when fluorous labelling takes place in solution; there
doubly- and even triply-labeled cysteine-containing peptides are observed [72]. It is
proposed that interfacial reactions are subject to more steric hindrance and orientational
effects. This hypothesis agrees with a study that reported that an interfacial reaction can
differ dramatically from the corresponding solution-phase reaction [110].
4.2.4: Compatibility of fluorous-affinity enrichment methodology with MS/MS
sequencing
An ideal approach for the analysis of complex biosamples would necessarily
involve effective separation and enrichment of the analytes of interest, followed by
qualitatively identification of the targeted analytes using methodologies such as MS/MS
protein sequencing. Typically, the classic biochemical affinity method involving biotinstreptavidin pairs can complicate MS/MS spectra that make the results difficult to
interpret [103]. In this work a cysteine-containing peptide with a fluorous-affinity tag,
CRF17ASIQK , was subjected to collision-induced dissociation (CID) in the triple
quadrupole (QqQ) mass spectrometer to establish if fluorous-affinity NIMS can lead to
proper MS/MS sequencing and yield simpler spectra that can be readily interpreted.
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a)

b)

Fig. 4.9a): NIMS spectrum of a group of residues from a 200 fmol
BSA tryptic digest before washing. 4.9b): NIMS spectrum produced
at the same condition as 4.9a), but recorded after washing the chip
with 40% methanol in water solution containing 0.1% TFA. #
corresponds to peptide peaks detected by NIMS not containing
cysteine residues; * corresponds to peptide peaks containing cysteine
residues; & corresponds to one peptide fragment containing two
cysteine residues.
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The MS/MS spectrum of the analyte shown in Fig.4.10 is composed of multiple b
and y ion series. In general, y and b ions result from the cleavage of the CO-NH bond,
which is the most common one among three possible cleavage points in the formation of
peptide fragment ions. The numbering of y and b indicates which peptide bond is cleaved
based on counting from C- or N- terminus, respectively. No fragment ions from
perfluorous tag are observed. In most MS/MS spectra immonium ions, [H2N=CH-R1]+
(where R1 represents side chain group in amino acid residue), are often observed and
provide information on the types of amino acids present in the sequence.
Interestingly, the MS/MS spectrum of the cysteine residue containing a fluorous
tag in Fig. 4.10 exhibits a unique immonium ion of m/z 633, which is attributed to the
characteristic mass (76) of the cysteinyl immonium ion plus the mass of fluorous tag
(557). This characteristic ion can serve as a marker to confirm if any given species is
indeed labeled. These results are in good agreement with those observed by Brittain et al.
[106] and confirm that a fluorous-affinity tag does not complicate the MS/MS spectrum.
Instead, the presence of the tag makes the spectral interpretation simpler by providing a
distinctive marker for the tagged cysteine residues.
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Fig. 4.10: A MS/MS spectrum of fluorous-affinity labeled
peptide, CRF17ASIQK, produced by CID using [M+H]+ as
precursor. The top shows the complete peptide sequence of Y
and B ions which were assigned from mass differences
corresponding to the mass of amino acid residues. The graphic
in the top right corner exhibits how Y and B ions are cleaved.
The a2 ion, which is obtained by loss CO(28) from a b2 ion, is
often observed as a diagnostic for b2. # is an immonium ion
peak of fluorous-tagged cysteine residue at m/z = 633 with a
structure [H2N=CH-CRF17]+, where CRF17 is fluorous-tagged
cystenyl. * correspond to ions which have lost water or
ammonia.
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Chapter 5: Label-free kinase activity assay and inhibitor
screening using a fluorous-affinity NIMS chip
5.1: Background
Enzymes play a crucial role in regulating a wide range of life processes such as
cell growth, migration, differentiation and death [111, 112]. They are also widely used in
industry to screen for drug targets [113] and as biocatalysts in the manufacturing of
biofuels [114]. It is therefore important to develop rapid and sensitive methods to
elucidate enzyme catalytic mechanisms, characterize enzymatic activities, and to rapidly
screen for inhibitory compounds [115]. Most current enzyme assays make use of the
differences in spectroscopic properties between a substrate and a product during
conversion. Typical analytical technologies include the fluorescence and UV-Vis
absorption spectroscopy [116, 117]. Although these methods are rapid, simple and
suitable when using high-throughput microtiter plates and microarrays [118-120], they
can suffer from limitations which include faulty outcomes caused by the introduction of a
fluorescence group into the substrate to overcome the fact that most naturally occurring
substrates do not readily exhibit any absorption or emission properties in the optical
regime [121, 122]. Derivatization can also change the kinetic properties of the substrate
and perturb the absorption and fluorescence spectra of enzymes, cofactors and/or buffers
in the reaction mixtures [123].
Radioactivity assays of enzyme-catalyzed reactions rely on substrate radioactive
labels. Although the use of radioactively-labelled substrates preserves the chemical
integrity of the substrate, the synthesis of radioactive-labelled compounds can be quite
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laborious, and the handling and ultimately disposal of radioactively “hot” materials
requires strict safety protocols [115].
MS is a technique that is ideally suited for enzymatic activity assays and inhibitor
potency screening because mass detection is a direct measurement, and product formation
can be readily established by simply measuring the reactant-product mass differences
resulting from the enzyme reaction [124]. One of earliest techniques developed was GCMS to monitor volatile by-products of enzyme reactions [125, 126]. Subsequent
development of ionization techniques such as thermospray MS and fast atom
bombardment (FAB) MS allowed polar substrates and products in aqueous solutions to be
measured [127-130]. Protein kinase assays were also developed obtained imaging
peptide-conjugated gold nanoparticles using SIMS [131].
The attractiveness of MS over UV-Visible absorption spectrometry, fluorescence
and radioactivity detection stems from its ability to perform enzyme assay using labelfree substrates, thereby circumventing the often laborious and costly protocols associated
with substrate labelling. Unlike fluorescence-based assays, mass detection avoids sample
autofluorescence and/or light scattering, thereby reducing the number of false positives
and negatives during high-throughput screening for enzymatic inhibitors [132].
Furthermore, unlike label-based detection, mass detection can be used to simultaneously
monitor the concentrations of a range of compounds during an enzyme-catalyzed reaction
including those of substrate, product, possible cofactors, coenzyme, and any internal
standards [133, 134].
Today, MALDI and ESI MS have emerged as powerful methodologies capable of
directly measuring substrates and reaction products [112, 135-137]. Recently, the

95

capabilities of MALDI MS have been extended to include imaging (MALDI IMS) [131,
138]. DIOS MS has also been used to measure enzyme substrate kinetics by analyzing the
residue of a reacting enzyme and substrate droplet as it travels down the length of a
porous silicon microfluidic channel [138].
Despite the power of MALDI MS it possesses a number of inherent limitations
including the presence of “sweet spots”, areas on the solid solution surface where MALDI
ion signal intensities are particularly intense. These are due to the heterogeneity of the
solid solution formed when the matrix and analyte are co-crystallized. Quantitative
analyses are therefore extremely challenging because of the resultant shot-to-shot
variability [5]. Furthermore, low molecular weight substrates and products can be readily
masked by strong matrix signals. Similarly, a difficulty associated with high throughput
enzyme inhibitor screening based on ESI MS, is the need to desalt the sample which
significantly slows down the analysis and increases its cost [124].
The new desorption/ionization technique of NIMS, which uses ‘initiator’
molecules trapped within a nanostructured material to assist the release and ionization of
intact molecules adsorbed on that material's surface upon laser or ion irradiation, has a
number of features which can overcome the limitation noted above for MALDI MS and
ESI MS [30]. The advantages of NIMS over MALDI MS and other surface
desorption/ionization techniques include higher analyte sensitivity and simpler sample
preparation; the latter is due to the fact that NIMS is "matrix-free" in that the analyte is
not co-crystallized with the initiator.
The sensitivity and throughput of enzyme assays can be markedly improved by
transforming conventional solution-based approaches to those involving an immobilized
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phase [139]. For example, the evaluation of ligand–receptor interactions and enzymatic
activities using peptide chips [140-144], is seen as an attractive option. Many enzyme
processes, including kinase [145] and protease[146, 147] activities, can be readily studied
using peptides as model substrates.
Recently the use of biochips based on fluorous-affinity interactions has emerged
as a new technique for studying biological systems [104]. This approach takes advantage
of a fluorous tag immobilized on the surface of a biochip to capture analytes of interest by
fluorine-fluorine interactions. When combined with mass spectrometry, it can through onsite enrichment provide rapid and sensitive analyses of targeted species [107]. As a proofof-principle experiment, a NIMS enzymatic assay, or "Nimzyme", was developed to
detect both addition and cleavage reactions by enzymatic catalysis of sialyltransferase and
galactosidase with extremely high sensitivity (subpicogram level) [71]. In this way the
enzyme activity of crude cell lysates from thermophilic bacteria could be directly
characterized. In addition, fluorous-affinity immobilization has been used to construct
small molecule microarrays for the analysis of carbohydrates [61] and for highthroughput enzyme inhibitor screening for drug discovery [55].
In this work, substrates containing cysteine residues were anchored to a NIMS
chip and used to detect kinase activities for the first time by employing a fluorous affinity
tag of 3-(perfluorooctyl)-propyl-1-maleimide. This “soft” immobilization, which is
accomplished by non-covalent fluorine-fluorine interactions, allows enzyme substrates
and reaction products to be efficiently desorbed and subsequently ionized in a mass
spectrometer. This methodology was first demonstrated by our group for a rapid
screening protein kinase A (PKA, Fig. 5.1 [148]) activity assay for different peptide
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substrates. A multi-kinase activity assay was also demonstrated using such fluorousaffinity NIMS chip which incorporated a mixture of kinase-specific peptide substrates.
The enzymatic inhibition potency was characterized by an IC50 value obtained by directly
measuring the ratio of substrate-to-product concentrations against known inhibitors for
PKA and Abl protein tyrosine kinase (Abl, Fig.5.2, [149]).

Fig. 5.1: The crystal structure of protein kinase A (PKA) [148].
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Fig. 5.2: The crystal structure of Abl protein tyrosine kinase (Abl) [149].

5.2: Results and discussion
Previous experiments using fluorous-affinity NIMS chips have demonstrated that
a desired subset of analytes (e.g. peptides containing cysteine residue) can be efficiently
isolated and enriched from extremely complex samples such as a BSA protein digest, as
described in chapter 4. There, a cysteine-containing peptide substrate was anchored to the
surface of a fluorous-affinity NIMS chip by a simple and highly selective Michael
addition reaction between thiol and maleimide groups [108]. In this work, the strategy
takes advantage of surface-immobilized substrates to perform an enzyme activity assay to
provide a quantitative evaluation of enzyme inhibition to demonstrate that inhibitor
screening can be done rapidly. The workflow designed for this experiment is shown in the
Fig. 5.3. First, a crude mixture containing a particular substrate, or a substrate mixture

99

2

1

3

4

Fig. 5.3: Schematic diagram for NIMS-based assays: 1. A specific class of substrate
peptides is captured by fluorous phase interactions with a fluorous affinity tag
immobilized on a NIMS chip. 2. An enzyme such as protein kinase A (PKA) is added
onto the NIMS chip; 3. A product such as phosphorylated peptide is produced by the
enzyme reaction. 4. The substrate and product are detected by NIMS.

containing many types of species is loaded onto a NIMS chip with a specific fluorous
affinity tag. Next, an enzyme in a reaction buffer solution is added onto the loaded
fluorous-affinity NIMS chip allowing the dissolved enzyme molecules to diffuse to the
sites at which the substrates are bound. After the enzyme catalytic reactions are
completed the chip is eluted with a fluorophobic solvent such as 40% methanol water
solution with 0.1% TFA to remove any residual nonfluorous compounds that are not
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bound to the fluorous affinity tag, salts and other contaminants. This step does not affect
the bound substrates or products with fluorous tags. Finally, the NIMS chip is subjected
to mass spectrometry analysis. The feasibility of a kinase PKA assay using this
methodology is demonstrated here by analyzing a mixture of three peptides (Pep1, Pep2
and Pep3), where only substrate Pep2 contains a cysteine residue.
5.2.1: Enzymatic activity assay of PKA with fluorous-affinity NIMS chip
Protein kinases are enzymes that catalyze the transfer of a phosphate group to
tyrosine, serine or threonine residue of a substrate protein [142]. They play a crucial role
in regulatory functions of all cellular processes including cell growth, migration,
differentiation and death [111]. Hence, kinase activities assays are extreme important for
developing lead compounds for drug discovery.
In this work fluorous-affinity NIMS chips were developed as an assay for protein
kinase A (PKA) activity. The substrate chosen for study was a peptide (Pep2,
LRRASLGC) containing both cysteine and serine residues. This allows it to be both
easily immobilized by the fluorous-affinity NIMS chip and to be phosphorylated by the
PKA enzyme. Fig. 5.4a shows a single major peak at m/z 1433 corresponding to the
protonated product of Pep2 having the fluorous affinity tag. After treatment with PKA
using the procedure described above the original peak corresponding to the substrate
peptide disappeared, and a new peak was observed at m/z 1513 (Fig. 5.4b) which
corresponds to the peptide having been phosphorylated. The expected mass change of 80
confirms the addition of the phosphate group to the peptide substrate by PKA, as shown
in Fig. 5.5. The peak intensities also suggest that fluorous affinity immobilization does
not significantly interfere with the reactivity of either the enzyme or the substrate.
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a)

b)

[Pep2+RF17+H]+
m/z 1433

[Pep2+RF17+P+H]+
m/z 1513

Fig. 5.4a) The mass spectrum of a substrate (Pep2) with fluorous tag
before adding the PKA enzyme. b) The mass spectrum after adding
PKA. The major peak corresponds to phosphorylated Pep2 resulting
from the reaction of the substrate with PKA.
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Adenosine triphosphate (ATP)

Adenosine diphosphate (ADP)

OH

Substrate peptide
(LRRASLGC)

H2PO4

PKA

Phosphorylation
product (LRRAS(p)LGC)

Fig. 5.5: Schematic diagram of phosphorylation reaction under assistance of protein
kinase A (PKA), which can catalyse the transfer of ATP terminal phosphate to
peptide or protein substrates at serine or threonine residues.

A substrate mixture composed of three peptides: Pep1, Pep2 and Pep3 was next
spotted into the chip surface as a model system to evaluate the utility of fluorous-affinity
NIMS chips as an enzymatic activity assay for complex biological samples. The
phosphorylation reaction was allowed to proceed at 30oC in a water bath chamber for 30
min. The chip was then rinsed 3-5 times using a 40% methanol water solution and places
in the mass spectrometer for NIMS analysis. As expected (Fig. 5.6), only the Pep2
substrate was phosphorylated. This shows that the methodology developed here is
suitable for the direct analysis of complex mixtures.
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[Pep3+H]+
m/z 1061

a)

[Pep1+H]+
m/z 726

[Pep2+RF17+H]+
m/z 1433

[Pep2+RF17+P+H]+
m/z 1513

b)

Fig. 5.6a) Mass spectrum of a mixture of peptides (Pep1, Pep2 and
Pep3) obtained using a fluorous-affinity NIMS MS chip before
adding kinase PKA. b) Mass spectrum of the products formed
from the mixture in a) after the addition of PKA and rinse using a
40% methanol water solution.
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5.2.2: NIMS chips for multiple kinase activity assays
Mass spectrometric techniques can provide information on both the extent of a
reaction (percent conversion of substrates) and help to identify the products. These
attributes provide an advantage over other enzyme activity assays (e.g. fluorescence and
radioactivity assays) that typically provide information only on the extent of a reaction.
Here we demonstrate that fluorous-affinity NIMS chips are capable of simultaneously
measuring the PKA activity of multiple substrates. Specifically, a mixture of two peptides
(Pep2 and Pep4, IYAAPKKKC, Fig. 5.7) was anchored to the maleimide-terminated
surface of a fluorous-affinity NIMS chip. The resultant NIMS mass spectrum exhibits two
well resolved peaks corresponding to the protonated tagged peptides: [Pep2+RF17+H]+
and [Pep4+RF17+H]+ (Fig. 5.8a).

Fig. 5.7: The chemical structure of Pep4 (IYAAPKKKC).
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[Pep2+RF17+H]+ m/z 1433

a)

[Pep4+RF17+H]+ m/z 1579

[Pep2+RF17+P+H]+ m/z 1513

b)

c)
[Pep4+RF17+P+H]+ m/z 1659

Fig. 5.8: NIMS spectra of obtained for the simultaneous measurement
of multiple kinase activities. a) the NIMS spectrum of substrate
peptides of LRRASLGC (Pep2) for PKA and IYAAPKKKC (Pep4)
for Abl. b) the NIMS spectrum obtained after adding PKA. Only
Pep2 has been phosphorylated. c) the NIMS spectrum obtained after
the addition of Abl. Only Pep4 has been phosphorylated.
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For comparison, PKA was added into a completely identical fluorous-affinity
NIMS chip where only Pep2 was expected to be phosphorylated. This can be confirmed
by examining Fig. 5.8b). Here the mass peak corresponding to the phosphorylated Pep2 is
observed while Pep4 is unaffected. In a separate experiment, an identically-prepared
NIMS chip was treated with kinase Abl which was expected to react specifically with
Pep4. As shown in Fig. 5.8c), Pep4 is phosphorylated while Pep2 was unaffected. These
results show that a single fluorous-affinity NIMS chips can be used to rapidly and easily
characterize different enzyme reactions for substrate mixtures.
5.2.3: Quantitative analysis of enzyme inhibition by product/substrate ratio
measurements
It is well-known that MALDI MS sample inhomogeneity results in poor sampleto-sample and shot-to-shot reproducibility. Although various strategies have been
developed to minimize these problems [123], these methods increase the complexity of
sample preparation, decrease detection sensitivity or require extra clean-up steps to
reduce ion suppression caused by contaminating salts.
A near ideal quantitative analysis strategy would involve monitoring the relative
ratio of the substrate/product intensities by MS. This ratio is a direct measure of enzyme
activity and inhibition without internal standards [150-152]. In such methods, ion
intensities for the substrates and products of each enzyme reaction are used to calculate
the percent conversion (% C) of a substrate to product, and subsequently, the percent
maximal activity (% MA) in a manner similar to previous reports [150, 153, 154]. % C is
defined as the product ion intensity (Ip) divided by the sum of the substrate ion intensity
(Is) and Ip multiplied by100% [150]:
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% C = [Ip / (Ip + Is)] × 100%

(5.1)

% MA is defined as the degree of enzyme inhibition to which the % C from the control
reaction (no inhibitor) has been diminished in reactions that contain an inhibitor based on
Eq 5.2 [153]:
% MA = (% C with inhibitor / % C without inhibitor) × 100%

(5.2)

The average background signal, which is taken as any product signals in the absence of
the enzyme, was routinely subtracted from all % C measurements prior to calculating %
MA [153]. IC50 values are calculated from a 10-point sigmoidal dose response curve,
which is a plot of log [inhibitor] against % MA.
Greis and colleagues [124] investigated the validity of the assumption that
simple products/substrates for enzyme ratios retain a linear relationship thereby allowing
for accurate and quantitative measurement using known molar ratios of products and
substrates for PKA spotted onto a MALDI probe for analysis. The plot of the percent
product from MALDI-TOF MS against the known molar ratios showed that the
phosphorylated products had a slight under-estimation compared to the known molar
ratios in positive ion mode while a slight over-estimation in negative ion mode, as shown
in the Fig. 5.9 [124]. One could expect that the negative ion mode favor the ionization
and detection of the phosphorylated product due to its increased acidity in contrast to the
substrate peptides. Whatever the case, what is the most important is that the
product/substrate ratios produce a good linear relationship with their molar ratios in both
cases and can be used to directly compare relative enzymatic activity for inhibition
measurement.
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Fig. 5.9: Plots of the percent product measured by MALDI-TOF MS using CHCA
as matrix versus the indicated molar ratios onto the MALDI target plate
demonstrated validation of product/substrate for enzyme ratios served as a
quantitative enzyme assay without internal standards. The dashed line represents
the theoretical linear relationship if the MS readout matched the molar ratios (i.e.,
the substrate and product had equal ionization and detection efficiencies) [124].

109

The quantitative nature of the enzyme assay without internal standards developed
was validated in this work by NIMS detection using a standard substrate peptide,
LRRASLGC, for kinase PKA and its phosphorylated product, LRRAS(p)LGC. Fig. 5.10
shows a plot of the percent product peptide positive ion NIMS intensity normalized by the
sum of the intensities of substrate and product peptide signals versus the percent number
of moles of phosphorylated peptide in a 200 fmol peptide mixture. The correlation is
excellent (R2 = 0.9959) and the slope (0.738) is closer to the theoretical value (1) than that
(0.684) [124] from MALDI MS detection Greis and colleagues did, presumably because
the sample distribution is more homogeneous on a NIMS plate than in a MALDI matrix.
The validation of the NIMS detection as a feasible alternative to enzymatic
inhibition assay was also evaluated by determining the half maximal inhibitory
concentration (IC50) values, which is a measure of the effectiveness of a compound in
habiting biological or biochemical function, for two known inhibitors: staurosporine
(Stsp; Fig. 5.11) and Imatinib(originally STI571; Fig. 5.12). Stsp is a non-selective potent
inhibitor against a variety of protein kinases including PKA [155]. The IC50 value of 20
nM was obtained from a 10-point dose-dependent inhibition assay plot of log [Stsp]
against %MA (Fig. 5.13a). This agrees well with the IC50 values of 25-50 nM from
MALDI MS studies and 20-60 nM using fluorescence detection [154].
Imatinib is an inhibitor of Abl, a drug used to treat certain types of cancer [156].
An IC50 value of 79 nM for Imatinib against Abl was obatined from Fig. 5.13b, which
also agrees with prvious reports [142, 157-159]. These results demonstrated that fluorousaffinity NIMS can be effectively used for quantitative assays of kinase activities and its
inhibition.
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Y = 0.738X – 0.183
R2 = 0.9959

Fig. 5.10: Validation of the simple quantitative kinase PKA enzyme
assay without internal standards by NIMS detection. In this
experiment a standard substrate peptide, LRRASLGC, was used
which was phosphorylated by the enzyme to produce the product
peptide, LRRAS(p)LGC. The percent product peptide ion intensity
over the intensity sum of substrate and product peptide from NIMS
detection in positive ion mode is plotted against the percent number of
moles of phosphorylated peptide in the 5 replicates with 200 fmol
peptide mixture each.
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Fig. 5.11: The chemical structure of the PKA inhibitor staurosporine.

Fig. 5.12: The chemical structure of the Abl inhibitor imatinib.
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a)

b)

Fig. 5.13a) a 10-point dose-dependent inhibition assay curve obtained by
plotting the log [Stsp] against degree of enzyme inhibition, %MA. b) a similar
assay curve of the Abl inhibitor imatinib. Note that X means the log inhibition
concentration.
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5.2.4: A potential platform for enzyme inhibitor screening
Rapid compound screening for enzyme inhibition was next investigated using a
fluorous-affinity NIMS chip. As shown in Fig. 5.14 Stsp and two classes of compounds,
A (chemical structure shown in Fig. 5.15) and B (chemical structure shown in Fig. 5.16)
as examples randomly chosen from chemicals library in our lab, were evaluated as
inhibitor of kinase PKA using a NIMS chip having four dot array format. One of the dots
contained no compound and was used as a control. A comparison of the mass spectra of
the three classes of compounds with that of the control dot (Fig. 5.17) shows immediately
that Stsp is the most potent inhibitor (as expected) while compound A was the least.
Given that fluorous-affinity immobilization has been successfully used to construct small
molecular microarray [61] and that NIMS has been shown to be effective at
characterizing a peptide microarray [30], it is expected that the fluorous-affinity NIMS
methodology will find applications as high throughput enzyme inhibitor screening
methodology for drug discovery.
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2
4

1
3
Fig. 5.14: A cartoon of a 2 x 2 NIMS chip array. Dot1 is a
control region of the chip where an enzyme and substrate have
been added but not an inhibitor. Dot 2 is a region of the NIMS
chip where the enzyme, the substrate in Dot 1, and a known
inhibitor have been added. Dot 3 corresponds to a region of the
NIMS chip where the enzyme, substrate, and potential
inhibitor calix[4]arene have been added. Dot 4 corresponds to
a region of the NIMS chip where the enzyme, substrate, and
potential inhibitor C-methylcalix[4]resorcinarene have been
added. Note that the area of each dot is ~3.14 mm2, and here
the dots are not drawn to scale.
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Fig. 5.15: The chemical structure of compound C-Methylcalix[4]resorcinarene.

Fig. 5.16: The chemical structure of compound Calix[4]arene.
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[Pep2+RF17+P+H]+
m/z 1513

a)

[Pep2+RF17+H]+
m/z 1433

b)

c)

d)

Fig. 5.17: The fluorous-affinity NIMS chip was used to perform
enzymatic inhibitor screening in 4-dot format. a): NIMS spectrum of
phosphorylation of substrate Pep2 for PKA without inhibitor and
other compounds (Control); b): NIMS spectrum after adding a known
inhibitor, staurosporine; c): NIMS spectrum after adding compound
A, Calix[4]arene; d): NIMS spectrum after adding compound B, CMethylcalix[4]resorcinarene.
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Chapter 6: Measurement of enantiomeric excess by
kinetic resolution and NIMS
6.1: Overview
The term: enantiomeric excess (ee) was originally defined to describe
enantiomeric composition of an optically active substance, as shown in Eq. (6.1) [160].
ee

(6.1)

where F is the mole fraction of each enantiomer and F+ + F- = 1. In practice, it can be
determined using the equation (6.2) [161] as a percent ee if the amount of each
enantiomer produced was known.
(6.2)
where R and S are the respective fractions of enantiomers in a mixture such that R + S =
1.
Recently, ee values have been used to quantitate stereoselectivity; that is, the ee
value is taken as a measure of how optically pure a substance is or alternatively, the
degree of contamination by the “opposite-handed” enantiomer of a chiral compound
[161]. An intriguing reason to measure the ee of organic molecules is to discover new
enantioselective catalytic processes by testing a great number of catalyst candidates [162].
The simplest strategy to rapidly determine the ee of a chiral molecule is to use
circular dichroism (CD) to directly measure the angle through which plane polarized light
is rotated after passing through a sample. However, this approach has two problems that
make it difficult to utilize in a practical manner. First, the sensitivity of this approach is
relatively low and second, the results are susceptible to impurities, particularly if they are
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chiral [28]. In general, the most widely used strategy for determining ee is to first
physically separate enantiomers by HPLC or GC using a chiral stationary phase, followed
by detection of the purified enantiomers using UV-visible spectroscopy [163, 164].
However, this method is often slow, expensive, tediously complex and may require
labeling with a chromophore [27].
MS as a chiral detection technology was firstly developed by Fales and Wright in
1977 [165]. Since then, many other MS methods have been developed to rapidly measure
ee values [27, 166, 167]. For example, Tao and Cooks used ESI-MS to determine low ee
values from the difference in rates of dissociation of chiral ligands from gas-phase copper
complexes generated in situ with the analyte of interest [166]. Siuzdak, Finn and others
employed automated quantitative ESI-MS [167] and chip-based DIOS MS [27],
respectively, to perform measurement of ee by kinetic resolution. This approach relies on
the principles of double asymmetric induction to resolve enantiomers by selectively
reacting one enantiomer of a racemic mixture with a chiral reagent, catalyst, or enzyme
[161]. The advantages of MS detection are that many different types of molecules can be
detected with high sensitivity without the need of a chromophore, it is tolerant of
impurities (mass peaks other than those for the compounds of interest can be ignored),
and potentially it is amenable to high-throughput applications [28].
In this work, a strategy was developed to measure the ee of analyte of interest
based on kinetic resolution and NIMS. It involves fluorous-phase diastereoselective
derivatization of the analyte, 1-phenylethanol (compound a) in Fig. 6.1), with chiral
reagents having fluorous tags of different mass (compounds b) and c) in Fig.6.1). The
compound is spotted on the surface of a NIMS chip covered with a thin film of initiator
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(the perfuorinated siloxane, BisF17). As shown in Fig. 6.1 this approach provides kinetic
resolution, followed by direct product NIMS detection. Compared to other methods based
on MS, the strategy here requires less sample preparation, is more tolerant to buffers,
impurities and other potential contaminants, and is highly sensitive.

a)

b)
+

1-phenylethanol
(enantiomers of
different ratios
or an
enantiomerically
pure sample)

DCC
DMAP

+

CH2Cl2

The products of
esters were
directly detected
by NIMS

c)

Fig. 6.1: A scheme showing the reaction of 1-phenylethanol (enantiomers of
different ratios or an enantiomerically pure sample) with equivalent fluorousmass tagged chiral acids.
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6.2: Determination of ee based on kinetic resolution and NIMS
Enantiomeric excess is defined as the absolute difference between the mole
fractions of an enantiomer pair. In practice, it is most often expressed as a percent
enantiomeric excess (% ee) [161]. The % ee of an analyte can be determined based on the
ability of a chiral reagent or catalyst to selectively derivatize one enantiomer of the
analyte in the presence of the other. As a general rule, an enantiomeric mixture of
alcohols, R-OH (R configuration) and S-OH (S configuration) will react with chiral masstagged acids A-CO2H (R configuration) and B-CO2H (S configuration), as shown in the
Fig.6.2.

B-COOH
(S configuration)

A-COOH
(R configuration)
A-COOR
Fast, kf

R-OH
(R configuration)

Slow, ks

B-COOR

Mass2

Mass1
+
A-COOH
(R configuration)
A-COOS

Slow, ks

S-OH
(S configuration)

B-COOH
(S configuration)
B-COOS
Fast, kf

Fig. 6.2: A schematic diagram of the generalized reactions of chiral
alcohols with mass-tagged chiral acids in a kinetic resolution process.
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In general, the reactions of the enantiomers of any pair of chiral reagents will
proceed with non-equal rate constants (kf > ks; f: fast, s: slow). Specifically, a reaction
will be fast for “matched” sets of reagents; for example, an R-alcohol reacting with an Racylating agent. On the other hand, the reaction rate of an S-alcohol reacting with an Racylating agent will be small (ks) [28]. If the kinetic resolution selectivity (p) is known,
where p is defined as the relative rates of the competing fast and slow processes, the
relative amounts of the product esters produced using the scheme in Fig. 6.2, measured in
this work by mass spectrometry, can be used to determine the enantiomeric composition
of the analyte using Eq. 6.3.

(6.3)
where

,

(

).

6.3: Results and discussions
In this work an equimolar mixture of pseudoenantiomeric fluorous mass-tagged
chiral acylating agents (b), R configuration and c), S configuration) were used that differ
in a substituent remote to the chiral center, bearing C6F13 and C8F17, respectively, such
that the mass of the molecule is correlated to its absolute configuration (R configuration
acylating agent is 565 Da and S is 665 Da). As shown in the Fig. 6.1, first, 1-phenylethanol was reacted with a 20-fold excess of an equimolar mixture of acids b) and c) in
the presence of 1,3-dicyclohexylcarbodiimide (DCC) and the catalyst 4Dimethylaminopyridine (DMAP) on the surface of a fluorous phase NIMS chip according
to the experimental methodology described in Chapter 2.3.5. The products were detected
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directly by NIMS using a nitrogen laser (337 nm) putting out 4 ns 5 µJ pulses at a
repetition rate of 10 Hz.
The kinetic resolution selectivity factor (p) was obtained by the known % ee of 1phenylethanol and the relative amounts of the acylated products using Eq. 6.4 which was
derived from Eq. 6.3.

(6.4)

For the enantiomerically pure compound (100% ee), a value of p =
= y = 2.4 ± 0.3 was established by averaging the ratio of signal intensity

for ester sodium adducts from three NIMS spectra because the peak signal intensity of the
protonated products is less than that of sodium adducts. Fig. 6.3 showed a representative
NIMS spectrum of a crude acylation reaction mixture obtained using a pure R
configuration alcohol (Fig. 6.4).
With the p value obtained from an optically pure sample, 1-phenylethanol was
then prepared in 80%, 60%, 40% and 20% enantiomeric excess ((R-S)/(R+S)), performed
chemical reaction according to the scheme shown in the Fig. 6.1, and the % ee determined
by measuring the relative amounts of the esters from mass-tagged acids b) and c) using
NIMS (BisF17 as the initiator). The results shown in Table 6.1 were obtained by averaging
three NIMS spectra for each sample and the observed values are well within the ± 10%
error range characteristic of MS enantiomeric excess determination (MSEED) method
devised here [28].
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+

+Na

+

+Na

Fig. 6.3: A typical 337 nm NIMS spectrum of the products from the
reaction of pure R-1-phenylethanol with equimolar mixture of
pseudoenantiomeric fluorous mass-tagged chiral acylating agents (b)
and c)). The initiator used was BisF17.
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a)
DCC

b)
+
+
1-phenylethanol
(an R
configuration
enantiomerically
pure sample)

DMAP
+b)

+

CH2Cl2

+

c)
c)
Fig. 6.4: A scheme of 1-phenylethanol (an R configuration enantiomerically pure
sample) reacting with equivalent fluorous-mass tagged chiral acids.

Table 6.1: NIMS analysis of 1-phenylethanol enantiomeric excess
using fluorous mass tags b and c
Actual % ee

80

60

40

20

Measured % ee

86 ± 7

63 ± 5

38 ± 3

22 ± 2
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Chapter 7: An exploration of visible-NIMS and NIMS
using WO3 and TiO2 substrates
7.1: Visible laser NIMS
7.1.1: Overview of visible MALDI and SALDI
The vast majority of MALDI mass spectra and almost all SALDI mass spectra
have been acquired using either UV [84, 168] or IR [169] lasers as irradiation sources for
desorption and ionization. Relatively few studies have been carried out using visible
lasers (400 nm - 750 nm) due to scarcity of known suitable organic matrix molecules that
can absorb visible light. Yet despite this MALDI MS using visible wavelength lasers is
expected to exhibit several advantages over UV-MALDI and IR-MALDI. For example,
many macromolecules of interest have UV light absorbing chromophores but are
transparent at visible wavelengths making them more stable against fragmentation under
visible irradiation [170, 171]. Furthermore, coherent radiation in the green portion of the
visible spectrum at 532 nm can be readily generated by frequency-doubling the IR output
of a Nd: YAG laser. Nd: YAG lasers are relatively inexpensive solid state devices that
have intense outputs and can be operated for long periods of time compared to the laser
most commonly used for UV-MALDI; namely, the N2 gas laser (337 nm) [172]. There
have been a few reports published where compounds such as Rhodamine dyes (RB, R6G)
[171, 173], neutral red [174] and 2-amino-3-nitrophenol [175] have been used as matrixes
for 532 nm-MALDI MS.
The Lipson group has explored the suitability of number of organic laser dyes as
visible-MALDI matrices including Coumarin 480 which absorbs near 480 nm [176], and
Rhodamine dyes (R575, R610) which under specific conditions proved to be viable media
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for small molecular weight analyte detection by 532 nm irradiation [177, 178]. Despite
these successes none of compounds appear to be as effective as the standard UV MALDI
matrices CHCA and DHB. Recently, Au-assisted visible-MALDI [179] and visibleSALDI using gold nanorods [180] as well as graphite substrates [181] have emerged as
more promising approaches for the development of visible laser MS.
NIMS based on pSi can be initiated using a nitrogen laser or various ion sources
(Au+, Ga+, Bi+ and Bi3+) [30]. One might expect that a visible wavelength laser could also
be used as a NIMS irradiation source because pSi absorbs strongly throughout the UVvisible spectrum [182]. In this work, we demonstrate that ions can be generated by NIMS
on pSi using the 532 nm output of a frequency-doubled Nd-YAG laser. The hexapeptide
Dalargin was used as a test analyte to assess the viability of visible-NIMS.
7.1.2: Results and Discussion
NIMS substrates were made by etching a silicon wafer electrochemically in
HF/ethanol solution. Coherent radiation at 532 nm was generated by frequency doubling
the output of a Q-switched Nd: YAG laser (Quanta-Ray GCR-4; λ = 1064 nm; 10 Hz
repetition rate) in a KDP nonlinear crystal, as described in Chapter 2. The 532 nm laser
beam was introduced into a 100 µm diameter optical fiber using a 5 cm focal length lens
and directed towards the sample plate of the mass spectrometer. Fig. 7.1 shows that the
visible laser NIMS mass spectrum of Dalargin (2 pmol) using BisF17 as the initiator
molecule exhibits strong analyte signals with low background noise. The peaks at m/z 726
and 748 correspond to protonated Dalargin ([Dalargin + H]+) and the sodium ion adduct
of the Dalargin ([Dalargin + Na]+), respectively.
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[Dalargin + H]+

[Dalargin + Na]+

Fig. 7.1: Visible NIMS spectrum of Dalargin (2 pmol) using
BisF17 as initiator and the 532 nm output of a Nd-YAG laser
operating at a 10 Hz repetition rate.

The [Dalargin+H]+ NIMS peak maximum at m/z 726 was used to determine the
LOD. The noise in a S/N evaluation was determined by measuring the average value of
the pure noise level between m/z 723 and 725 over ~1000 laser shots, each pulse having
20 μJ of energy. The average S/N values obtained reflect both the instrumental and
chemical noise due to the residual contamination on the NIMS surface. The amount of
Dalargin irradiated by the laser beam was calculated based on the ratio of the laser spot
area to the whole sample surface area of the NIMS chip. The laser was repositioned 5
times to different locations on the NIMS chip, and each run at a specific location was
repeated 5 times and the ion intensities averaged. A S/N ratio = 3 was considered the
minimum value that would allow the peak signal to be clearly differentiated from the
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noise, thereby giving an indication of the lowest concentration that could be measured
reliably.
A standard curve made by plotting the S/N of the visible laser NIMS intensity
measurement for Dalargin against number of moles of Dalargin in the spot as shown in
Fig. 7.2. A linear regression of the data yielded a R2 value of 0.9963 and a LOD of (3.1 
0.7) × 10 -14 mol. This result shows that visible-NIMS is ~50 × less sensitive than UVNIMS ((6.4  0.3) × 10 -16 mol; Chapter 3), and requires higher pulse energies. However,
this constitutes a 15 x improvement in the LOD for Dalargin by visible-MALDI MS ((2 
1) × 10 -13 mol) using the best visible binary matrix (R575 + HCl) and the same mass
spectrometer [177].

LOD: (3.1 ± 0.7) × 10-14 mol at S/N = 3:1

Fig. 7.2: A plot of the S/N ratio of the protonated Dalargin visible-NIMS
signal versus the number of moles of Dalargin in the sample.
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Since the home-made MALDI source employed in this work is typically about
one order of magnitude less sensitive than a commercial MALDI-TOF instrument under
similar fluencies (but different energies and spot sizes) [177], it is believed that the
analyte detection limit can be improved using a modern MALDI-TOF mass spectrometer
with a better ion transmission efficiency and a laser operating at 532 nm.
7.2: New NIMS substrates: microstructured WO3 and porous TiO2
As described in Chapter 1, NIMS is very similar to DIOS except that it uses a
liquid initiator such as fluorinated or perfluorinated siloxane propellant to facilitate
desorption of intact analyte. NIMS takes advantage of both the basic principles of DIOS
but because a liquid initiator is involved it also has some features which are similar to
MALDI. Some of the benefits of NIMS include a much better sensitivity than DIOS: only
700 yocto-mol (10-24 mol) for calcium antagonist erapamil (~ 420 molecules), and a
relatively simple sample preparation. NIMS works well under both laser and ion beam
(Au+, Ga+, Bi+ and Bi3+) irradiation [30].
DIOS (the forerunner of NIMS) was introduced in 1999 and was the first SALDI
method that used a specific substrate such as pSi to assist in the desorption and ionization
of the sample molecules [9]. Since then, a variety of nanomaterials have been explored as
possible substrates for SALDI MS. They include carbon nanotubes [183], microstructured
tungsten oxide [75], porous alumina [184], silver nanoparticles [185], platinum
nanoflowers [186], gold nanomaterials [187, 188], nanotitania [189], and so on. To the
best of our knowledge, only pSi to date has been utilized as a substrate for NIMS.
This thesis focuses on two particularly promising candidates: microstructured
WO3 and porous TiO2 as possible NIMS substrates. The WO3 chip, which was developed
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in the Lipson group, is an excellent substrate for SALDI MS because it has been shown to
be effective in detecting low-molecular weight compounds in both positive- and negativeion modes, as well as radical cations of compounds which are difficult to protonate and/or
deprotonate [75]. In the latter case, WO3 chip should be useful for charactering non-polar
or conducting polymers and functional dendrimers. TiO2 semiconducting nanoparticles
are widely used in the field of photocatalysis and as a component of dye-sensitized solar
cells [190]. Like pSi, WO3 and TiO2 have many properties such as high melting points,
low heat capacities (Cp) and relatively low thermal conductivities (k), which make them
excellent substrates for SALDI MS. In this study, WO3 and TiO2were tested as potential
NIMS substrates using BisF17 as the initiator. The hexapeptide Dalargin was used as the
test analyte.
7.2.1: WO3 chip as a NIMS substrate
The experimental details for making microstructured WO3 are presented in
Chapter 2. Briefly, a WO3 chip for NIMS analysis was produced by irradiating tungsten
foil for 40 minutes in methanol with the 355 nm output of a frequency-tripled Nd-YAG
laser (intensity ~ 4-5 W/cm2). The resultant chip was then heat activated by placing it in
an oven for 4 hours at 275 0C. As shown in Fig. 7.3, The SEM image of a typical WO3
substrate exhibits a mixture of pores, crevices and protrusions with dimensions ranging
from nanometers to micrometers in size.
The NIMS process was initiated by a 337 nm N2 laser operating at a 10 Hz
repetition rate. Each pulse had an energy of 10 µJ. Fig. 7.4 shows the NIMS mass
spectrum of Dalargin (0.5 pmol). The peaks at m/z 726 and 748 correspond to [Dalargin +
H]+ and [Dalargin + Na]+, respectively.
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Fig. 7.3: SEM image of a microstructured WO3 substrate for
NIMS produced by irradiating W foil for 40 minutes in
methanol with the 355 nm output of a frequency-tripled NdYAG laser at an intensity of ~ 4-5 W/cm2, followed by heat
activation.

[Dalargin + H]+

[Dalargin + Na]+

Fig. 7.4: NIMS spectrum of Dalargin (0.5 pmol) from a microstructured
WO3 substrate using BisF17 as an initiator. The NIMS process was
initiated using 337 nm output of a N2 laser operating at a 10 Hz
repetition rate and having an energy of 10 µJ/pulse.
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7.2.2: TiO2 chip used for NIMS substrate
Fig. 7.5 shows SEM images of the resulting TiO2 substrate produced by an
electrochemical etching process in 1 M H3PO4 containing 0.5 wt% HF acid in which a
potential was ramped from 0 V to 10 V at a sweep rate of 500 mV/s followed by holding
the potential at 10 V for 500 seconds (Chapter 2). Under these conditions the TiO2 chip
surface consists of pores with diameters of approximately a few tens of nanometer.

Fig. 7.5: SEM image of porous TiO2 substrate for NIMS produced by
electrochemical etching in 1 M H3PO4 containing 0.5 wt% HF acid.
Here the potential was ramped from 0 V to 10 V at a sweep rate of
500 mV/s followed by holding the potential at 10 V for 500 seconds.

Fig. 7.6 shows the NIMS spectrum of Dalargin (1 pmol) obtained from porous
TiO2 substrate using BisF17 as the initiator and 15 µJ pulses of a 337 nm N2 laser at a
repetition rate of 10 Hz. While the resultant mass spectrum using TiO2 is similar to that
obtained using WO3, higher laser energies are needed to obtain the same degree of
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analyte sensitivity as that obtained with a WO3 substrate.

[Dalargin + H]+

[Dalargin + Na]+

Fig. 7.6: NIMS spectrum of Dalargin (1pmol) from a porous TiO2
substrate using BisF17 as an initiator. The NIMS process was
initiated using the 337 nm output of a N2 laser operating at a 10 Hz
repetition rate and having an energy of 15 µJ/pulse.

Overall, both WO3 and TiO2 appear to be less effective than pSi as NIMS
substrates. However, the NIMS performance could be further improved by refining the
fabrication of the WO3 and TiO2 chips. Metal-based materials can also possibly overcome
the fragility found for pSi.
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Chapter 8: Mechanisms of laser desorption/ionization
by MALDI and NIMS
8.1: MALDI
MALDI is an extremely complicated “event” involving optical, mechanical,
thermodynamic and physicochemical processes related to phase transitions and ionization
phenomena [3]. There is an on-going debate about the MALDI desorption/ionization
mechanism at the molecular level. Its resolution has been complicated by the large
number of critical parameters involved including the incident laser wavelength and pulse
duration, laser fluence, the structure of the solid solution made by co-crystallizing an
analyte and matrix, the sample preparation protocol, and so on.
Despite the complexity of the problem, a “two-step” model which first involves
the formation of primary ions followed by secondary ion generation within the desorption
plume expansion is now widely accepted [191]. As shown in the Fig. 8.1[191], the “twostep” model differentiates the time scales of the decay of the optically excited primary
ions (on the order of nanoseconds) [192] and the expansion of the MALDI plume (on the
order of microseconds) [8]. Three aspects of the MALDI mechanism will be discussed
here in more details: the primary laser desorption and ionization steps, secondary ion
formation, and some of the key parameters influencing the MALDI process.
8.1.1: Desorption in MALDI
The first step in the MALDI mechanism involves the laser excitation of the
matrix molecules in the solid solution containing the analyte of interest [3]. A large
portion of the incident laser energy is rapidly converted to heat resulting in an explosive
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formation of a gaseous material plume. In general, a high-quality MALDI mass spectrum
is linearly correlated with the degree of matrix optical absorption [193]. The population of
the first excited singlet state (generally S1) obtained by resonant optical absorption is
considered the primary excitation step [194]. Apart from some energy loss caused by
fluorescence, intersystem crossing and photochemical reactions, most of the laser energy
that is stored in the excited states of the matrix is subsequently converted by nonradiative
relaxation into intramolecular lattice vibrations (i.e. heat) on a time scale of nanoseconds
or faster [192, 195].

Fig. 8.1: Density changes with time during plume expansion in a MALDI
process. The inset shows the initial behaviour in which the lower and
upper curves represent a typical laser pulse and an average lifetime of
matrix excited state, respectively; the dashed line is for a phase explosion
while the solid line is for desorption [191].

A number of models have been proposed to explain the phase transition that
occurs during the MALDI desorption step. For example, it has been suggested that
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thermal desorption takes place by sublimating or evaporating individual molecules layerby-layer from the surface inward [196-198]. In another, molecules and clusters of
molecules are ejected by volume ablation [199]. For IR-MALDI the ejection of bulk
material could result from a laser-induced photoacoustic stress pulse generated within the
matrix made possible by the relatively larger laser penetration depths at those
wavelengths [3].
Generally, sublimation/evaporation-like processes occur at low laser fluences
below or close to the ion detection threshold. Although a small number of clusters may be
generated at low laser fluences, individual molecules are the predominant species ejected
in the plume [3, 194]. Assuming that yield of ejected molecules is proportional to the
desorption rate which in turn is dictated by the temperature increase generated by the
incident laser, the overall yield can be expressed as [200]:
Y ~ P(A) exp(

(8.1)

where Y is the yield (amount) of the ejected molecules, P(A) is a pre-exponential factor
which is an entropy-related term with a weak temperature dependence, Ea is the activation
energy of the desorption process; kB is the Boltzmann constant; T0 is the initial sample
temperature; η is a conversion factor that is designated to the transformation of laser pulse
energy into (lattice) temperature of the sample, and F is the laser fluence.
At higher laser fluences, molecule desorption is governed by volume
photoablation. This corresponds to an explosive phase change where the desorption rate is
less than the rate of laser energy deposition into the matrix, resulting in an overheated
sample [201]. In this case, the overall material yield, Y, which includes molecular
clusters, is better fitted by an equation of the form: [199]
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Y ~ δ ln

n

(8.2)

where δ is the penetration depth of the laser irradiation, Ev* is a critical energy density, c
is the specific heat of the material; n is an integer = 1 for a flat-top beam profile and 2 for
a Gaussian beam profile. Note that Eq. 8.2 is only valid for fluences F >

[3].

The actual desorption process depends substantially on the properties of the laser
(wavelength, fluence, pulse duration, etc.) and the matrix material used in a MALDI
experiment, making a detailed understanding challenging [199]. The initial plume
densities are also very large which means that the ejected material undergoes a large
number of intermolecular collisions upon desorption. These collisions are expected to
have a significant effect on the expansion characteristics and inevitably lead to
considerable dynamical changes during the material expansion [194].
8.1.2: Ionization in MALDI
8.1.2.1: Primary ion formation
The mechanism of primary ion formation which occurs during or shortly after the
laser pulse has irradiated the solid solution remains controversial. Two competing models
have emerged as front runners to explain this phenomenon: energy pooling [191] and
cluster ionization [202].
The energy pooling model: Energy pooling is a phenomenon which occurs in the
gas phase between neighbouring excited molecules [203, 204]. Upon photoexcitation to
their first excited singlet state (S1) neighbouring molecules either collisionally and/or
electronically undergo singlet-singlet (S1-S1) annihilation promoting one of the partners
into their second excited state (S2) while relaxing the other to ground state (S0) [192].
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This process can carry on between S1 and Sn≥2 partners until finally ionization takes place.
Pooling would be of the limited importance for MALDI if only excited analyte
pairs were involved. However, energy pooling is possible by interactions between analyte
and matrix molecules [205]. The excitation within matrix clusters can "hop" between
cluster components relatively easily (excitonic behaviour). This and energy pooling can
substantially increase the ionization efficiency because there is less dependence on where
the excitation in the cluster "sits". The intermolecular pooling and hopping processes
involving neighbouring matrix molecules are sketched in Fig.8.2 [191]. Evidence for S1S1 pooling has been deduced by fluorescence quenching studies, while energy pooling of
a S1 molecule with a higher excited state, Sn was demonstrated by a 2-pulse time-delayed
(between 2-3 nano-second) MALDI experiment [195].

Fig. 8.2: Schematic of the pooling and hopping processes
involving neighbouring matrix molecules. S0 is the
electronic ground state, S1 the first singlet excited state,
and Sn an excited state above S1 [191].
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The cluster ionization mechanism: Typical MALDI analytes such as peptides,
proteins, nucleotides and so on are believed to be pre-charged in the solid matrix solution.
Thus, the primary ions can be formed by separating preformed analyte ions from their
counter ions or by neutralizing their counter ions [202]. In general, there are two main
pathways which can generate charged species. The most straightforward ionization route
is by charge separation in clusters having a deficit/excess of ions [206]. The other is
cluster photoionization, in which charge separations are achieved by performing
photoionization and losing the resultant electrons from the materials [207, 208].
The energy required to overcome ion-pair interactions is expected to be supplied
by the energy released from cluster dissociation. This energy requirement may be reduced
by residual solvent, that is, partial solvation via a dielectric screening effect, and by any
hydrogen-bonding with matrix molecules [202]. Once charged clusters are produced, the
final ions formed result from desolvation of matrix and/or residual solvent. The efficiency
of ionization by charge separation is dependent on the acid-base properties of the analyte,
matrix and additives, their solvation properties, and how they are incorporated into the
solid matrix solution [209].
In addition to these two models, other mechanisms have been proposed for
primary ion formation, including multiphoton ionization, Excited State Proton Transfer
(ESPT), and a polar fluid scenario. Direct multiphoton ionization of matrix or matrix–
analyte complexes comes about by the coherent nonlinear optical absorption of two or
more photons. While feasible, the incident fluence must be high; usually higher than the
typical fluence values used in MALDI experiments [194].
ESPT is an attractive ionization mechanism in that it is a one-photon event at UV
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excitation wavelengths which can occur in the S1 excited state. However, an ESPT
pathway is not generally expected to dominate in MALDI mass spectrometry because
molecules capable of proton transfers require an environment that efficiently stabilizes
charge separation [204]. For example, known ESPT systems are often only active in
water or amine environments. Direct evidence of ESPT involving matrix molecules such
as DHB has not been found in either solution or in gas-phase clusters of DHB and
analytes [210].
In the polar fluid model, the vaporized matrix behaves like a warm dense polar
fluid solvent that allow free ions to be stabilized. Since the interactions between the polar
fluid and analyte are energetic enough to ionize organic acids, it promotes the separation
of previously associated ions, resulting in free, mobile solvated protons and alkali ions
[211]. While the polar fluid picture continues to be incorporated as a part of molecular
dynamics (MD) simulations of the MALDI picture, it is not considered to be the
fundamental basis for ion separation [191].
8.1.2.2: Secondary ion formation
Understanding the secondary reactions that take place in the MALDI plume is
important because these reactions have a major, even definitive impact on the observed
mass spectrum. Secondary reactions lead to essentially the same observed mass spectra
regardless of the mechanism involved in primary ion formation [191]. The matrix is the
dominant neutral partner in secondary ion formation reactions because it is nearly always
present in substantial excess; the ion-to-neutral ratio in MALDI is typically 10-4-10-7
[212, 213]. The following are some of the possible ion-molecule reactions leading to
secondary ion formation:
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Proton transfer: Proton transfers between either a protonated, deprotonated or
radical matrix molecule and a neutral analyte molecule are probably the most important
secondary reactions in MALDI since energetically they tend to be highly exothermic.
The reactions can be written as:
[M + H]+ + A → M + [A + H]+

(8.3)

[M - H]- + A → M + [A - H]-

(8.4)

M.+ + A → [M - H]. + [A + H]+

(8.5)

where M is a matrix molecule or cluster; M.: is a radical matrix , A is an analyte and H is
a proton.
Neutral analytes such as peptides and proteins tend to have somewhat higher
proton affinities (PAs typically ≥ 900 kJ/mol [214, 215]) than typical matrix molecules
(between 850 and 900kJ/mol) [216-218]. In negative ion detection mode, the difference in
the gas-phase basicities (GPBs) of the deprotonated analytes and the matrix anions
determines whether proton detachment from a neutral analyte molecule is energetically
feasible [194].
Cation Transfer: Adducts of an analyte with various cations can be unwelcome
in a MALDI mass spectrum if the signals for the protonated species are already intense.
However, it can be very useful for some analyte molecules such as oligosaccharides and
synthetic polymers which have low PAs relative to that of the matrix. In these cases, such
analytes can be preferentially detected as cationized species. The species are generally
detected as [A + Na]+ or [A + K]+ because these alkali cations are ubiquitous in most
experimental apparatus [219].
Electron transfer: Electron transfer from either the analyte to matrix cations or
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from neutral matrix molecules to analyte ions is the simplest type of matrix-analyte
secondary ion-molecule reaction [220-222]. The former is represented by:
M+ + A → M + A+

(8.6)

The reaction is efficient only when ionization potential (IP) of the matrix is greater than
that of the analyte; otherwise the analyte is not ionized [8].
Electron Capture: Electron capture reactions are thought to play an important
role in producing the singly charged ions that are prevalent in MALDI mass spectra
[206]. Photoelectric emission from any metal surface in the MALDI instrument exposed
to the incident laser beam can produce substantial quantities of free electrons, especially
since the presence of matrix or contaminants in small amounts on the metal can reduce
the work function of the metal [223]. Electron capture mass spectra of a series of typical
MALDI matrixes have been investigated [36]. The results suggest that the process of free
low-energy electron capture by matrix molecules is one origin of negative ions.
Secondary ion-molecule reactions not only explain which ions are observed in the
final mass spectrum, they also help to understand another feature of MALDI; namely, the
matrix suppression effect (MSE) [8]. MSE is a rather general phenomena in MALDI, in
which matrix ions can be completely suppressed at certain analyte concentrations [224].
However, the phenomenon was not fully understood until it was placed in the context of
the two-step picture and interpreted as a consequence of secondary reactions [191]. When
the reactions of primary matrix ions with analytes are thermodynamically favourable as
secondary reaction processes, they can proceed to completion. The degree of matrix
suppression depends on the matrix/analyte (M/A) concentration ratio [7]. In MALDI MS
of caffeine using CHCA as matrix, for example, the matrix suppression is nearly
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completed in mass spectrum when the M/A ratio is ~ 3 (large amount of analyte), while
more matrix signals appear in the spectrum when the amount of analyte is less (M/A =
27) [8].
8.1.3: Some key parameters influencing desorption/ionization process
In general, MALDI is strongly dependent on the laser irradiation conditions
including the laser wavelength and laser fluence. MALDI also depends on the materials
making up the matrix.
8.1.3.1: Laser wavelength and matrice absorption
It has been recognized since the early days of MALDI that the matrix must absorb
at the incident laser wavelength to obtain a high-quality mass spectrum [168, 225].
Typically the intensity of the features in the mass spectrum is dependent on a matrix’s
molar absorption coefficient at the incident wavelength and increases with increasing
matrix absorption. The best mass spectra are obtained using a laser wavelength that
corresponds to the absorption maximum of the matrix [193, 211]. A matrix with a lower
absorption coefficient can be used however by irradiating the sample with a higher
fluence at the appropriate wavelength. However, analyte ions will not be produced if the
absorption approaches some critically low value [211].
The spectral absorption spectrum of a solid matrix can differ considerably from its
solution spectra. Solid-state absorption spectra tend to broaden toward longer
wavelengths, that is, to the red [226, 227]. One potential benefit of the broadened solid
phase absorption profile is that MALDI laser wavelengths can be used that lay outside
their solution absorption bands [3].
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8.1.3.2: The effect of laser fluence on MALDI ion signal intensity
Laser fluence is defined as the pulse energy per unit area. This metric strongly
influences the observed ion signal intensities in a MALDI mass spectrum [3]. In general,
the ion signal intensities increase steeply with laser fluence above a threshold value where
MALDI ions are first detected [228, 229]. However, it is also observed that at fluence
levels 2-3 times the threshold value the ion signal intensities do not increase appreciably
[200]. This is attributed to the side effects such as fragmentation reactions or absorption
saturation [3]. Indeed, these factors can reduce the MALDI ion signals [229].
Often the MALDI ion signal, I, dependence as a function of incident laser fluence,
F, is represented by an equation of the form I ~ Fn [230, 231]. The exponent n is
dependent on the matrix and the instrumental configuration used in a MALDI process, as
well as the laser spot size [200, 229]. Typically values of n have been determined
between 5 and 10 from MALDI spectra obtained using laser spot sizes of 50-200 µm in
diameter [3].
8.1.3.3: Sample preparation protocols
It is well-known that the protocols used to make a matrice-analyte sample play a
key role in a successful MALDI MS analysis. For example, a proper M/A ratio is
indispensable for obtaining a MALDI mass spectrum with a good signal-to-noise ratio in
that the quality of the mass spectra deteriorate significantly if the ratio is too high or too
low [232]. Generally, the critical value of the M/A ratio increases with the molecular
weight of analyte. The solvent, buffers and other detergents used in sample preparation
process can also affect the MALDI MS performance [233-235]. A comparison of dry and
wet depositions of analyte on matrice crystals reveals that it is crucial to sufficiently rewet
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the matrice surface layers with analyte solvent to optimize the MALDI performance
[236]. In contrast to ESI, however, MALDI is relatively more tolerant toward impurities
such as salts.
There are many approaches to making solid matrice-analyte solutions. Two of
them: the “dried-droplet” and “thin-layer” protocols are widely used for MALDI MS
analyses. In the dried-droplet method, matrice and analyte are co-crystallized by simply
mixing their solutions together and slowly air-drying. For the thin-layer protocol volatile
solvents such as acetone or acetonitrile facilitate a fast evaporation of solvent and the
formation of homogeneous microcrystalline “films” [3]. Interestingly, both yield very
different sample morphologies but similar MALDI mass spectra. This suggests that
sample morphology is less important for a successful MALDI analysis [233].
8.2: DIOS
Although the DIOS mechanism is currently not well understood, many operational
aspects of MALDI also apply to DIOS. Both, for example, use a laser pulse to excite and
desorb the analyte, and both involve a thermal desorption process, and ion formation by
intermolecular reactions such as proton transfers. Thus, insight into the DIOS mechanism
is helped by first understanding the MALDI desorption/ionization process described
above. At the same time there are some significant differences between the two methods.
8.2.1: The desorption process in DIOS
In general, the desorption process involves the absorption of laser irradiation by a
solid substrate and subsequent transfer of that energy to the analyte, resulting in its
movement from the solid substrate to the gas phase. It has been demonstrated that
photoactive and photo-luminescent pSi efficiently absorbs UV-visible light [237]. At the
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N2 laser wavelength of 337 nm, for example, pSi can have an effective absorption
coefficient of up to 105 cm-1 [238].
Another very useful property of pSi is its ability to use the absorbed laser energy
to form energetic electron–hole pairs or excitons [78]. Electron–hole pairs separate within
the space-charge layer located in the surface of pSi, thereby creating an electric field, and
when they relax via nonradiative recombination of electrons and holes or carrier–phonon
scattering, surface adsorbates can become vibrationally excited [239]. It has been
calculated that the band gap at the surface of pSi is reduced to 0.65-0.25 eV which is
similar to the band gap energies of nanosized Si clusters such as Si11, Si14, Si17, Si18, Si30
and Si33, (0.4-0.6 eV) [240].
One mechanism proposed to explain the analyte desorption in DIOS is the high
peak temperatures obtained by laser irradiating the strongly absorbing pSi which results
in part from its poor thermal contact with the underlying bulk material [241, 242]. Similar
to MALDI, the analyte phase change is a thermal vaporization process which is induced
by the heating of the substrate surface by the incident laser. The laser-induced
temperature increase in the surface is determined by two effects: heat conduction and
laser light absorption. For example, when a pSi substrate is irradiated by a 337 nm N2
laser the surface temperature is estimated to reach as high as 600 K [243]. Unlike the
MALDI plume which expands in three dimensions, the DIOS expansion is onedimensional due to the confinement imposed by the porous structure. Since the resulting
plume cannot expand freely, the plume density remains elevated for a longer period
relative to a free expansion [244]. In addition, solvent remains trapped in the nanopores
by capillary forces which can lead to very large long-range density fluctuations and may

147

induce a transition from bulk liquid to a two-dimensional adsorbate phase [245]. This
gives rise to a high-density solvent plume containing the adsorbate.
Desorption in DIOS is determined in part by the interaction between the pSi
surface and the analyte. This surface interaction energy is expected to influence the
energy transfer during the desorption event. In general, the activation energy barrier to
release the analyte from the surface,
rate,

, controls the rate of desorption. The desorption

, can be expressed by an Arrhenius-type equation:
(8.7)

where A is a pre-exponential factor related to the frequency of attempts to cross the
barrier.

is dependent on the interactions between the pSi surface and the adsorbate

molecules as well as the surface coverage because of possible interactions between the
adsorbates [241].
8.2.2: Ion formation in DIOS
8.2.2.1 Primary and secondary ionization
The effects of some fundamental and experimental parameters (for example, pSi
preparation method, pore size, laser wavelength, sample composition, pH, and so on [15,
25, 243]) on the performance of DIOS have been studied. However, it is still not
completely understood how ionization occurs under DIOS conditions. One thought is that
the optical absorption and thermal conductivity properties of pSi provide enough energy
to promote analyte desorption and ionization. The two-step framework, which is
emerging as a viable model to explain MALDI [191] may also apply to DIOS; that is,
primary ions are first generated within the time scale of the laser irradiation pulse while
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secondary ions are formed by ion-molecule reactions in the expanding plume.
Primary ion formation is an extremely complicated process and may involve
several possible pathways. Photoexcitation and energy pooling is thought to be a possible
mechanism because electronic structure of a pSi surface can support exciton formation
[239]. As described in 8.1.2.1, exciting the analyte in its S1 state can lead a higher excited
Sn state by exciton migration and pooling. Subsequently, energy pooling by species in
their S1 and Sn states produces the primary ions. In some cases, pre-existing ions or ion
pairs can be present in the nanopores. These ions can be separated and released from the
surface by the accelerating voltage of the mass spectrometer and/or the electric field of
the incident laser beam [77].
Ion-molecule reactions similar to those described above for MALDI may also be
important in the DIOS plume. These include excited-state proton transfers from the
excited Si-H groups to the analyte, electron transfers to and from the surface, as well as
cationization. For organic compounds with high aqueous basicities, proton transfer
reactions to form protonated molecules [A+H]+ may take place via a Si-O····H-A
complex. The adsorbed water plays an important role here because water dissociates upon
adsorption and becomes incorporated into the pSi surface as Si-OH. In general, only basic
analytes with the aqueous pKa values > 4 can be effectively ionized according to this
model [246]. In some cases, cationization by Na+ and K+ is the dominant process in
positive ion detection [247, 248], especially when the proton affinity of the analyte is
small [8].
A complete understanding of MALDI and DIOS involves not only the desorption
and ionization process, but also any chemical reaction that the analytes undergo within
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the gas phase plume [249]; for example, analyte reduction [250]. Studies of various
organic dyes with different reduction potentials by DIOS/MALDI MS have shown that
reductions were more obvious for the DIOS process compared to MALDI. When Cu(II)
ions were added as an electron scavenger the reduction processes were suppressed for
MALDI and not for DIOS. These observations were rationalized as follows: in MALDI
with thick sample layer where Photoelectric emission from any metal surface seldom
comes about, only a small number of electrons responsible for analyte reduction are
supplied by matrix molecules, which are effectively scavenged by the Cu(II) ions. In
DIOS however, the silicon substrate supplies a large number of electrons to the analytes,
making the Cu(II)-doping ineffective.
8.2.2.2: Proton source
In MALDI, the matrix is one of the major proton sources. It has been shown
through deuteration studies that proton exchange between the excited matrix and any
residual solvent in the matrix is unimportant [251]. In DIOS, it has been suggested that
the pSi surface can serve as a proton source. The hydrogen-rich pSi surface SiHx (x, ~1–
3) is a result of the anodic etching process in HF used to make the porous silicon [80].
One possible chemical reaction that describes the anodization is:
Si + 6HF → H2SiF6 + H2 + 2H+ + 2e-

(8.8)

Surface heating [252] and photochemical processes [253] are known to cause loss of
surface hydrogen from porous silicon, and this process does not fit a second order rate
equation. This suggests that hydrogen loss is not strictly in the form of molecular
hydrogen [254].
It is also important to note that solvent, water or residual hydrofluoric acid (HF)
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can provide protons for DIOS, and/or the trapped solvent and residual gas accumulated in
the pores can serve as photochemical ionization agents [241]. For example, an ion yield
enhancement of 10 to 40 times was found upon introduction of residual acetic acid or
water vapors, demonstrating that gas-phase species can also play a significant role in
ionization [243].
In general, the native pSi surface is terminated by Si-H bonds that are
hydrophobic. This surface, however, is not stable in air and it is gradually oxidized to
form surface Si-OH. It has been proposed that the hydroxyl surface terminations are an
important proton source for analytes with high PA. It was also found that fluorinated pSi
surface are advantageous because fluorine increases the acidity of the Si-OH moieties
[241].
8.2.3: Some pSi properties influencing DIOS performance
8.2.3.1: Porosity and surface structure of the pSi
The porosity and surface structure of porous silicon used in DIOS are known to
play important roles in desorption and ionization processes. Typical n-type DIOS surfaces
having porosities of 30-40% can have surface areas a million times greater than that of a
planar surface (~100 m2/cm2 of etched material). This high surface area significantly
lowers the melting point of silicon: pore coalescence and structural collapse were
observed at 900 °C [258] in contrast to the melting point of bulk Si (1410 °C) [256]. The
driving force for this melting process is an increase in the surface energy of pSi (0.2
J/cm2) relative to bulk Si (0.0001 J/cm2). This suggests that the pSi surface energy can be
decreased by surface diffusion of silicon atoms upon heating resulting in pore
coalescence; that is, larger pore radii and a smaller surface area [255]. For example, pSi
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will melt using typical nitrogen laser energies (~15 mJ/cm2) because the surface
temperature can rise as high as 600 K [257]. As a result, lower laser intensities are
required for DIOS experiments involving Si nanowire features [244].
The DIOS process is affected by the pSi surface structure. The correlation
between the DIOS performance and surface structure is determined by several factors
including the surface area, the nanoscale morphology leading to higher optical
absorptions, and the low resultant thermal conductivities [258]. Heat conduction, for
example, is inversely correlated with morphology; fine microcolumns lose heat radially at
a lower rate than the bulk material due to phonon confinement and boundary scattering
[259]. Furthermore, the morphological features of the pSi provide a framework in which
solvent and analyte molecules become trapped. Therefore, the combination of large
optical absorption coefficient (a ~105 cm-1 [260]) and low thermal conductivities
promotes efficient energy transfer from the substrate to adsorbed analyte molecules which
desorb intact upon irradiation with a pulsed laser [25].
8.2.3.2: Chemical properties of pSi surface
The chemical properties of pSi surfaces such as wettability, pH, and so on, are
also important for optimizing the performance of DIOS MS. The wettability of the
surface determines the distribution of the analyte inside the nanopores. Generally higher
wettability allows the analyte solution to penetrate deeper into the pore structure [241].
As noted previously, pSi freshly prepared by electrochemical etching is chemically
unstable because its Si-H terminated surface is susceptible to oxidization, resulting in the
change of surface wettability. This Si-H surface leads readily to a characteristic chemical
background in the DIOS mass spectra as it tends to trap hydrocarbons from the ambient
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environment [239]. Fortunately, both the wettability and the stability of the pSi surface
can be altered by surface derivatization [261].
The pH value of the sample also has a significant impact on the quality of the
DIOS mass spectrum. For example, peptide ion signals in negative-ion mode are
insignificant relative to the background noise using a low pH buffer solution. However,
the analyte signal improves greatly at a buffer solution of higher pH values with a
corresponding decrease in the background noise [25]. In some cases the gas-phase analyte
proton affinity turns out to be more important for enhancing its DIOS MS sensitivity than
its pKa value in solution [246].
8.2.3.3: Other influencing factors
In addition to the physical and chemical properties of the pSi substrate and
analyte, the characteristics of the irradiating laser pulse and other environmental factors
also affect the DIOS performance. For example, as noted above the laser fluence
thresholds for desorption and ionization are lower in DIOS than those in conventional
MALDI MS [18]. Similarly, the choice of laser wavelength is also important in this
regard. In general, fluence levels are lowest for UV lasers (for example, the 337 nm N2
laser output) and much higher using visible photons (for example, the 532 nm output of a
doubled Nd:YAG laser). Interestingly, the fluences required when using IR wavelengths
(for example the fundamental output of a Nd:YAG laser at 1.064µm) lie between the UV
and visible wavelength values. Like MALDI, above threshold, DIOS ion signal intensities
increase rapidly with increasing laser fluence, ultimately saturating at high fluence levels
[246].
The mass spectra generated by DIOS are less dependent on the wavelength of the
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laser because pSi can absorb at any photon energy exceeding the band gap of crystalline
silicon (1.1 eV). For example, the laser-induced microcolumn arrays on a silicon surface
exhibit a close-to-unity absorbance between the near UV (> 250 nm) and near-IR (< 2.5
μm) [262, 263]. This differs from MALDI, where a matrix’s ability to absorb the energy
of the laser and absorption efficiency are highly dependent on its molecular and electronic
structure [249].
Investigations have also shown that increasing the ion source pressure in the mass
spectrometer reduces the number of desorbed ions in a DIOS experiment. The amount of
water adsorbed on the pSi surface is also affected by the ion source pressure. Given that
the experimental conditions within the mass spectrometer are important, it should
probably not be surprising that there are inconsistent reports for the same type of
experiments in the literature [239].
8.3: NIMS
NIMS is related to DIOS but makes use of some of the advantages associated with
MALDI; specifically, the use of initiator molecules to facilitate desorption/ionization of
analytes from a nanostructure surface [32]. It is expected therefore, that many aspects of
the desorption/ionization mechanism in DIOS or MALDI will also apply to NIMS. For
example, NIMS takes advantage of the large optical absorptions of pSi to absorb laser
irradiation and effectively convert that energy into heat, resulting in an explosive
expulsion of the initiator molecules into the gas-phase facilitating the desorption of
adsorbed analytes [30]. It has been logically suggested that ion formation in NIMS also
take place by the two-step mechanism which has been used to explain the ionization steps
in MALDI and DIOS, (Sections 8.1 and 8.2). However, some features of NIMS are not
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well understood. For example, ion beams have been used instead of photons to form
intact analyte ions by NIMS. However, SEM images of the ion-radiated surfaces do not
reveal any obvious changes in nanostructure surfaces before and after a NIMS event. As
well, unlike conventional MALDI and DIOS, laser-NIMS can produce multi-charged
proteins similar to ESI [30].
Usually molecules such as fluorinated siloxanes serve as the initiators in NIMS
desorption and ionization. SEM imaging has shown that after laser irradiation, the pSi
surface used in NIMS is degraded. This is attributed to rapid surface heating which causes
the initiator adsorbed to the substrate to explosively enter the gas-phase [30]. The initiator
molecules however, are not ionized in the process because they are chosen to be
transparent to incident UV light [31]. Furthermore, because the initiator molecules are not
co-crystallized or incorporated with analyte molecules they are not really matrix
molecules. In this regard NIMS is fundamentally different from MALDI [32].
Although NIMS is a newly developed matrix-free desorption/ionization technique,
it has already proven to be useful for the analysis of complex biofluids and metabolites,
and for tissue imaging.
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Chapter 9: The SALDI ionization mechanism
9.1: Introduction
Surface techniques such as DIOS and NIMS have been successfully applied in the
analyses of small drug molecules, peptides, synthetic polymers and enzymes [9, 30, 83,
264]. As discussed in Chapter 8 however, the elucidation of the SALDI ionization
mechanism is controversial and elusive [239].
It is well-known that the ion signal intensity (I) of a particular analyte in both
MALDI and DIOS depends strongly on the laser influence (F) [18, 229]. Experimentally,
ion signals in a mass spectrum appear above a threshold fluence value, rise rapidly and
then saturate at high laser fluence. The signals can even decline at higher fluence values
due to the onset of side reactions resulting in fragmentation and substrate surface
deformation. That said, there is still a debate as to whether the threshold fluence is a
genuine physical attribute of the process versus an experimental limitation.
The ion signal intensities are observed to increase with a power-law of I ~ Fn in
the range between threshold and saturation [176]. In the case of non-resonant multiphoton
ionization (MPI), the slope of the ln-ln plot of I versus F, n, indicates the number of
photons involved in the nonlinear absorption process [265]. For organic molecules with
ionization potentials around 9 eV the number of photons involved tends to be ~ 2-3
(assuming that UV photons with energies of ~3.7 eV (337 nm) are used). The slopes of
the ln-ln plots in MALDI MS and DIOS however, tend to be very large (n between 4 and
10). In such cases equating the slope of these ln-ln plots with the number of photons does
not make physical sense.
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9.2: Small molecule ionization experiments using a pSi substrate
Caffeine (C8H10N4O2; molar mass = 194.2 gmol-1) is one of the most widely
consumed biologically-active substances and a well-known stimulant due to its action as
an antagonist to adenosine receptors in the central nervous system [266]. Its chemical
structure is shown in Fig. 9.1. Caffeine was used as an analyte to investigate the physical
processes taking place when using pSi for DIOS and NIMS because surprisingly its mass
spectrum exhibited two peaks; one corresponding to the radical cation as well as the
expected feature corresponding to the protonated species. The former are rarely observed
in MALDI, DIOS or NIMS. Furthermore, the relative intensities of these features were
found to depend critically on the location of the laser focus relative to the substrate
surface (Fig. 9.2). The two configurations (laser focus at the surface and above the
surface) are shown schematically in Fig. 9.3. Similar observations were subsequently
found in this work using other SALDI substrates such as microstructured tungsten oxide
(WO3) [75] and titanium dioxide (TiO2) [267] indicating that the mechanisms involved
are specific to the analyte but general with respect to the substrate provided the material is
porous and a semiconductor.

Fig. 9.1: Chemical structure of caffeine; C8H10N4O2;
molar mass = 194.2 gmol-1
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[C8H10N4O2 + H]+
a)

b)

[C8H10N4O2]+

Fig. 9.2: DIOS mass spectra of caffeine obtained a) when the incident laser
was focussed at the surface of the pSi chip and b) when the laser was
focussed above the surface of the pSi chip.

a)

b)

Fig. 9.3: Schematic diagram illustrating a) the incident laser
focused at the surface of pSi chip and b) the laser focussed
above the surface of the pSi chip.
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9.2.1 Ionization when the output of the laser is focussed at the surface of the pSi chip
The effect of laser fluence on the DIOS protonated caffeine signal (2µL, 1mM),
was studied by focusing the spot size of the output of a N2 laser to 7.85 × 10-4 cm2 at the
surface of a pSi chip and varying the pulse energy from 4 µJ to 25 µJ. As shown in Fig.
9.4 the slope of the ln-ln plot of analyte signal intensity versus laser fluence in this region
is ~4.6. The physical meaning of the slope in DIOS is obscured by the fact that
intermolecular reactions likely play a key role in determining the magnitude of the
analyte signals. As noted above it is highly unlikely that the slope in Fig. 9.4 corresponds
to the number of photons absorbed in the primary ionization step since the laser
intensities used were not particularly high, and the total energy corresponding to four or
more photons, if deposited into the analyte during the absorption step, would leave the
molecule well above its ionization potential (~7.91 eV [268]).
9.2.2: Ionization when the output of the laser is focussed above the surface of the pSi
chip
The dependence of the radical ion DIOS signal intensity of caffeine on the
position of the laser focus above the substrate surface was investigated (Fig. 9.5). As the
laser focus is moved above the surface the higher fluence in the focal volume is sampling
the plume above the surface rather than being deposited into the substrate. In this work
the distance was changed from 0.1 mm to 1 mm in intervals of 0.1 mm. The highest
radical cation signal intensity was obtained when d = 0.4 mm.
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Slope = 4.6 ± 0.2

Slope = 1.8 ± 0.2

Fig. 9.4: The ln-ln plots of the DIOS signal intensity of the protonated
caffeine ion (upper plot) and radical caffeine ion (bottom plot) versus laser
fluence when the output of the N2 laser (337 nm) was focussed at the
surface of the pSi substrate.
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Fig. 9.5: The DIOS-MS signal intensity of the radical caffeine ion as a function
of the distance between the laser focus and the surface of the pSi chip.
Fig. 9.6 shows that the ln-ln plot of the radical cation signal intensity versus laser
fluence has a slope of ~2.4 when the incident laser was focused 0.4 mm above the pSi
surface. This value strongly infers that a different mechanism is at play relative to that
suggested by the bottom trace of Fig. 9.4. Indeed, the slopes, which are derived from the
ln-ln plot of the radical cation signal intensity versus laser fluence, are what one might
expect for a multiphoton ionization process.
The effect of laser fluence on the NIMS spectrum of caffeine was also
investigated using compound BisF17 as an initiator and by placing the incident laser focus
0.4 mm above the substrate surface. Fig. 9.7 shows that the slope of the ln-ln plot of the
signal intensity of the radical cation versus laser fluence was ~1.9; again strongly
suggestive of a multiphoton ionization process. The signal intensity of radical cation is
dramatically increased relative to that of the protonated ion (Fig. 9.8) since the initiator
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(BisF17) is able to carry more caffeine molecules into the gas phase due to its volatility
under laser irradiation.

Slope = 2.4 ± 0.1

Slope = 4.9 ± 0.5

Fig. 9.6: The ln-ln plots of the DIOS-MS signal intensity of caffeine
versus laser fluence for the radical cation (upper plot) and the
protonated ion (bottom plot) when the output of the N2 laser (337 nm)
is focussed 0.4 mm above the surface of the pSi substrate.
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Slope =1.9 ± 0.1

Slope =4.9 ± 0.7

Fig. 9.7: The ln-ln plots of the NIMS signal intensity of caffeine versus laser
fluence, for the radical cation (upper plot) and protonated caffeine ion (bottom
trace), using BisF17 as an initiator and placing the focus of incident N2 laser
beam (337 nm) 0.4 mm above the surface of the pSi chip.
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[C8H10N4O2]+

[C8H10N4O2 + H]+

Fig. 9.8: NIMS spectrum of caffeine obtained using BisF17 as the
initiator and placing the focus of the incident N2 laser (337 nm)
0.4mm above the surface of the pSi chip.

9.2.3: Improving the ionization efficiency using two lasers
Timing plays an important role when post-ionizing neutrals in a two-laser
experiment because the distribution of laser-desorbed molecules at a given point in the
resultant gas expansion is itself time-dependent. In this work two lasers were used; a
doubled Nd:YAG laser (532 nm) to initiate desorption and a N2 laser (337 nm) to probe
the resultant gas plume. As shown in Fig. 9.9 the timing sequence begins by triggering the
Nd:YAG laser and an oscilloscope at the same time, which correspond to t = 0. The N2
laser was then fired after 191 μs when the Nd:YAG laser pulse comes out, with a variable
relative delay between 1 to 10 μs. The UV output emerged ~ 0.8 μs after the second
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trigger. In this way, the DIOS plume containing the analyte plume could be probed by the
N2 laser output at different stages of its development as it expanded away from the
surface.

Trigger Nd-YAG
laser pulse

191 µs

Laser pulse
532 nm

0.8 µs
191.2 ~ 200.2 µs
Trigger N2 laser pulse

N2 laser pulse
337nm

Trigger oscilloscope

t=0
Fig. 9.9: Time delay sequence for a two-laser post-ionization DIOS experiment.
The time axis as shown is not drawn to scale.
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The energy of the 532 nm Nd:YAG laser used for desorption was held at 25 μJ/
pulse, while the N2 laser energy was held at 5 μJ/pulse. The latter value is a little higher
than the threshold value needed to observe a DIOS signal with the experimental
instrumentation in the lab. This energy level was chosen to ensure that any signal
enhancement due to a two-laser DIOS experiment was more evident when comparing the
signals obtained by a single-laser DIOS run.
The enhancement for caffeine as a function of delay time using two lasers is
shown in Fig. 9.10. Each data point represents an average value of the ion signal intensity
of radical caffeine cation (2μL, 1mM) at m/z 194.2 acquired over 1000 scans between m/z
= 190 and 200. Figure 9.10 shows that the caffeine radical cation signal intensity is
enhanced by 337 nm UV post-ionization relative to that observed using nitrogen laser
alone, maximizing by ~80% at a time delay of ~ 5 μsec. The overall profile of the plot is a
measure of the time evolution of the plume, and shows that species are released slowly
(on the microsecond time scale) relative to the duration of the incident desorbing laser
pulse (nanosecond time scale).
Experiments were then carried out with the roles of the lasers reversed; that is, the
DIOS plume was generated by the UV output of the N2 laser (337nm) followed by postionization using the visible Nd-YAG laser output (532 nm) with the same pulse energy as
the N2 laser at a time delay of ~ 5 μsec. As show in Fig. 9.11, the radical cation peak
([C8H10N4O2]+) decreased significantly compared to observed with the original
configuration. This is attributed to the fact that it takes at least 4 photons of 532 nm light
(photon energy, 2.33 eV) to ionize caffeine (IP, ~7.91 eV [271]) compared to only 3
photons of 337 nm light (3.68 eV).
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Fig. 9.10: A plot showing the enhancement of the radical caffeine cation
signal intensity at m/z 194.2 produced by two-laser DIOS over a DIOS
experiment performed with a single laser, as a function of delay time.
These results indicate that the incident laser desorbs neutrals as well as ions and
that the neutral analyte molecules can be post-ionized after an appropriate delay relative
to the desorption laser. The time evolution of the analyte plume reflects the time scale on
which the substrate is heated by the incident laser pulses, which in turn is determined by
the heat capacity and thermal conductivity of the substrate material. At short delay time,
most of the desorbed neutrals have not yet reached the focal volume of the second postionization laser. At the longest delay time most of the neutrals have already passed
through the focal volume of the second laser pulse, and fewer molecules are being
desorbed. Therefore, the optimum delay corresponds to the time when the UV pulse
intersects the plume with the maximum number density of desorbed material. This occurs
after ~ 5 µsec for caffeine. This result indicates that on average the caffeine molecules are
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moving very slowly (assuming d = 0.4 mm, v = d/t ~ 80 ms-1) and therefore the expansion
is probably more effusive than supersonic in nature. The experiments here show that
compared to a single laser experiment the efficiency of radical cation formation during
DIOS can be increased by directly ionizing the expanding plume with a second laser after
an appropriate time delay. This implies that the approach described in this thesis may be
used to deliver biomolecules into the gas-phase for spectroscopic characterization.

[C8H10N4O2 + H]+
a)

[C8H10N4O2]+

b)

Fig. 9.11: DIOS spectra of caffeine obtained in a two-laser experiment
where a) DIOS was initiated with a N2 laser (337 nm) while the visible
output of a doubled Nd-YAG laser (532nm) was used for post-ionization
and b) DIOS was initiated with a double Nd:YAG laser (532 nm) while
the UV output of a N2 laser (337 nm) was used for post-ionization.
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9.3: Peptide ionization using a pSi substrate
The dependence of peptide analyte ion signal intensity on laser fluence by DIOS
was investigated using the hexapeptide Dalargin. First, a ln-ln plot of the protonated
Dalargin ion signal intensity versus laser fluence was made for the case where the
incident laser was focused at the surface of the pSi chip (Fig. 9.12a). The slope of the line
of best fit is ~ 5, a value which is very similar to that observed from MALDI (5~10)
depending on matrix and mass spectrometer used [200, 229].
Next, the ln-ln plot of the protonated Dalargin signal intensity formed by DIOS
versus laser fluence was measured when the laser focus was positioned 0.4 mm above the
surface of the pSi chip (Fig. 9.12b). The slope in this case is ~4, but unlike caffeine, a
radical cation peak ([Dalargin]+) is not observed in mass spectra while the peak due to
[Dalargin + H]+ is substantially decreased. Lastly, a ln-ln plot was made of the NIMS
protonated Dalargin signal intensity versus laser fluence using BisF17 as an initiator.
Slopes of n ~ 3.9 and ~ 4.5 were found when the laser was focused 0.4 mm above the
surface and at the surface, respectively (Fig. 9.13). Although the NIMS [Dalargin + H]+
peak signal intensity was significantly larger than that obtained by DIOS the radical
cation [Dalargin]+ was still not observed. This may be because the proton affinity of the
polypeptide is so large that any radical cations formed efficiently react with the substrate
or other molecules in the plume to form the protonated species. More experiments are
required however to confirm this hypothesis.
As explained below these results suggest that peptide desorption is initiated by a
thermal mechanism.
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a)

Slope =5.0 ± 0.1

b)

Slope =4.0 ± 0.1

Fig. 9.12: ln-ln plots of the protonated Dalargin ion intensity formed by
DIOS versus laser fluence when a) the focus of N2 laser (337nm) was
placed at the surface of the pSi chip, and b) when the output of the incident
N2 laser (337 nm) was focused 0.4 mm above the surface of the pSi chip.
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a)

Slope =3.9 ± 0.1

b)

Slope =4.5 ± 0.1

Fig. 9.13: ln-ln plots of the protonated Dalargin NIMS signal intensity versus
laser fluence using BisF17 as an initiator a) when the focus of N2 laser (337 nm)
was placed 0.4 mm above the surface of the pSi chip and b) when the focus of
N2 laser (337 nm) was placed at the surface of the pSi chip.
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9.4 Ionization process using different substrates
Recently microstructured tungsten oxide (WO3) and titanium dioxide (TiO2) were
developed as effective SALDI substrates and used to detect a variety of small drug
molecules and peptides [75, 267, 270]. Similar to the experiments described above, the
desorption ionization mechanisms using WO3 and TiO2 chips as SALDI substrates were
investigated by constructing ln-ln plots of the analyte ion peak signal intensity versus
laser fluence. Fig. 9.14 shows the results for caffeine (5µL, 1mM) obtained by using a N2
laser (337 nm) to initiate the SALDI process on a WO3 chip. The slope obtained from the
plot when the incident laser was focused at the surface of the chip is ~ 4.2 (the upper trace
in Fig.9.14) when detecting the protonated species, and ~2.4 (the bottom trace in the
Fig.9.14) when detecting radical molecular ion. The slopes obtained for the radical cation
and protonated species when the incident laser focus was placed 0.4 mm above the
substrate surface (the bottom trace in Fig.9.15) and at the surface (the upper trace in
Fig.9.15), are ~2.2 and ~4.9, respectively.
Similarly, the slopes obtained for protonated caffeine and the radical cation using
a porous TiO2 chip as the SALDI substrate are ~4.6 and ~3.0, respectively (Fig. 9.16)
when the focus of the N2 laser (337 nm) was located at the chip surface. Similar slopes of
~3.9 and ~2.0, (Fig. 9.17) were obtained when the focus of N2 laser was located d = 0.4
mm above the TiO2 chip surface for the protonated species and the radical cation,
respectively. These results are similar to those obtained using pSi, and show that while
the substrate must be porous the “chemical” identity of the substrate material appears to
be less important. All slopes derived from plots of ln(I) versus ln(F) for the formation of
of protonated and radical cations from Caffeine and Dalargin are listed in Table 9.1.
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Slope =4.2 ± 0.1

Slope =2.4 ± 0.2

Fig. 9.14: ln-ln plots of the SALDI ion signal intensity of protonated caffeine
(upper plot) and the radical cation (bottom plot) versus laser fluence using
WO3 as a substrate when the focus of the N2 laser (337 nm) was placed at the
surface of the chip.
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Slope =4.9 ± 0.3

b

Slope =2.2 ± 0.1

Fig. 9.15: ln-ln plots of the SALDI ion signal intensity of protonated
caffeine (upper plot) and the radical cation (bottom plot) versus laser
fluence using WO3 as a substrate when the focus of the N2 laser (337 nm)
was located d = 0.4 mm above the surface of the chip.
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Slope = 4.6 ± 0.2

Slope =3.0 ± 0.2

Fig. 9.16: ln-ln plots of the SALDI ion signal intensity of protonated
caffeine (upper plot) and the radical cation (bottom plot) versus laser
fluence using TiO2 as a substrate when the focus of N2 laser (337 nm) was
placed at the surface of the chip.
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Slope =2.0 ± 0.2

Slope = 3.9 ± 0.1

Fig. 9.17: ln-ln plots of the SALDI ion signal intensity of the caffeine
radical cation (upper plot) and the protonated species (bottom plot) versus
laser fluence using TiO2 as a substrate and placing the focus of N2 laser d =
0.4 mm above the surface of the chip.
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Table 9.1: Slopes derived from plots of ln(I) versus ln(F) for protonated and radical
cations formed using pSi, WO3 and TiO2 as SALDI substrates
Substrates

pSi

WO3

TiO2

Slope from focus of
laser located
at the surface of
substrate

Slope from focus of laser
located above
the surface of substrate
(d=0.4mm)

Protonated
Dalargin ion

5.0 ± 0.1

4.0 ± 0.1

Protonated
Caffeine ion
Radical Caffeine
cation
Protonated
Caffeine ion
Radical Caffeine
cation
Protonated
Caffeine ion

4.6 ± 0.2

4.9 ± 0.5

1.8 ± 0.2

2.4 ± 0.1

4.2 ± 0.1

4.9 ± 0.3

2.4 ± 0.2

2.2 ± 0.1

4.6 ± 0.2

3.9 ± 0.1

Radical Caffeine
cation

3.0 ± 0.2

2.0 ± 0.2

Analyte ions
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9.5: Discussion
The ln-ln plots of the SALDI analyte ion signal intensity, I, versus laser fluence,
F, are based on an ion signal fluence dependence of the form:
9.1
If the desorption/ionization mechanism involves a multiphoton process then “n” would be
identified as the number of photons absorbed by analyte. A 337 nm photon from a N2
laser has ~3.67 eV of energy. If the IP of a typical organic molecule is ~ 9.5 eV n would
be ~ 3. Therefore, an n ≥ four-photon process is considered to be highly improbable.
Conversely, if the ionization process is initiated by thermal desorption, the process
is expected to be governed by an Arrhenius equation of the form, as described in Chapter
8 [200]:
9.2
where Ea is the desorption activation energy,

is the Boltzmann constant, T is the

effective temperature at the substrate determined by the fluence of the incident laser
fluence:
9.3
and

is room temperature (298.15 K). Substituting Eq. 9.3 into Eq. 9.2 yields:
9.4

The constant η is a function of the physical properties of the substrate and determines the
conversion of the deposited energy into a temperature increase within the substrate
material. Assuming that complete thermal equilibrium is achieved, then [200]:
9.5
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where R are the reflection losses, a is the absorption coefficient, ρ is the density and C is
the specific heat capacity. The physical parameters for the SALDI substrates studied in
this thesis are listed in Table 9.2.
Table 9.2: Physical parameters for the SALDI substrates used in this thesis.
pSi

WO3

TiO2

Band gap energy
(eV)
R

2.2 [271]

2.75 [272]

3.2 [273]

0.22 [78]

0.18 [274]

0.12 [275]

a (m-1)

107 [260]

2 × 106 [276]

2.5 × 106 [277]

-

-

3.89 × 103 [278]

ρ (kg m-3)
k (W m-1 K-1)
-1

-1

C (J K kg ), or
Cv (J K-1 m-3)*
η (K m2 J-1)

1 [279]

1.63 [280]
6

1.3~5.6 [281]

6

0.7 × 10 by Cv
[279]

2.28 × 10 by Cv
[280]

688.64 by C [282]

11.14

0.72

0.82

* Cv is the specific heat capacity per unit volume and equal to ρC. The number in the
brackets are references.
In general, heating leading to a temperature increase within the substrate (ΔTs) is
determined by two effects: heat conduction and laser light absorption [243]. If the laser
penetration depth δd = 1/a where a is absorption coefficient, is much larger than the
thermal conduction depth δc = (

)1/2, where k is the thermal conductivity, C is the

specific capacity, and t is the length of the laser pulse, the substrate heating will be
determined essentially by direct local laser energy absorption. In this case, the substrate
temperature rise can be estimated using the following equation [243]:
9.6
where a, F and C have the same physical meaning as defined for equations 9.4 and 9.5.
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On the other hand, if δc > δd, the local temperature rise ΔTs will be limited by heat
conduction. In this case ΔTs can be calculated using [243]:
δc

9.7

In this work for example, if caffeine is desorbed and ionized by focusing 6 µJ of
337 nm N2 laser light (a typical laser energy used for DIOS; laser pulse duration t = 4 ns)
at the surface of pSi substrate, then δd = 1/a = 1/(107 m-1) = 0.1 µm > δc = (
µm. Under these conditions

)1/2 = 0.042

= 1091K; a value that is close to the value

obtained using Eqs. 9.3 and 9.5 (ΔT = T – T0 = 1149 -298 = 851 K). Therefore, it appears
that the heating process leading to desorption in pSi is determined mainly by direct laser
light absorption. It is predicted that over the range of laser energies used in this thesis (4
µJ to 25 µJ), the substrate temperatures ranged from 866 K to 3841 K under 337 nm
irradiation. At the higher incident laser fluences heat conduction effects are expected to
be important in preventing the substrate from melting.
Fig. 9.18 shows plots of ln (I) for the protonated caffeine ion versus 1/(T0 + ηF)
using pSi, WO3 and TiO2 as substrates when the focus of N2 laser (337 nm) is located at
the chip surfaces. If Eq. 9.4 is valid then the slope of the ln-ln plot is given by -Ea/kB. The
values of desorption activation energy (Ea) derived from the lines of the best fits range
between 0.54 and 0.77 eV (Table 9.3). These SALDI desorption energies are lower than
those derived from MALDI experiments (0.7 ~ 1 eV for typical matrix compounds [200])
which suggests that analytes are more readily desorbed from the condensed phase by
SALDI than by MALDI.
Different results are obtained for the caffeine radical cations. The plots of ln (I)
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versus 1/(T0 + ηF) when the focus of the N2 laser was located d = 0.4 mm above the
surface of the chip are shown in Fig. 9.19. The desorption activation energies Ea (0.26 ~
0.42 eV; Table 9.4) are smaller than those derived for the protonated species. Still overall,
the high quality of the fits in Figs. 9.18 and 9.19 strongly suggests that a thermal
mechanism is important in the formation of both protonated analyte and radical cations.

1/(T0 + ηF) (×10-3 K)
Fig.9.18: Plots of ln (I) for the protonated caffeine ion versus 1/(T0 + ηF)
using pSi, WO3 and TiO2 as substrates when the focus of N2 laser was
located at the chip surfaces.

Table 9.3: The slope and Ea values from plots of ln(I) for protonated Caffeine ion versus
1/(T0 + ηF) when the focus of the N2 laser was placed at the surface of the chip
pSi

WO3

TiO2

Slope (K)

-8898.7 ± 577

-6311.4 ± 273

-6729.5 ± 339

Ea (kJ mol-1)

73.9 ± 5

52.4 ± 2

55.9 ± 3

Ea (eV)

0.77 ± 0.05

0.54 ± 0.02

0.58 ± 0.03
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1/(T0 + ηF) (×10-3 K)
Fig. 9.19: Plots of ln (I) for the caffeine radical cation versus 1/(T0 + ηF)
using pSi, WO3 and TiO2 as substrates when the focus of N2 laser was
located d = 0.4 mm above the chip surfaces.

Table 9.4: The slope and Ea values from plots of ln(I) for Caffeine radical cation versus
1/(T0 + ηF) when the focus of the N2 laser was located d = 0.4 mm above the surface of
the chip
pSi

WO3

TiO2

Slope (K)

-4848.95 ± 188

-3795.62 ± 161

-3032.44 ± 158

Ea (kJ mol-1)

40.3 ± 2

31.5 ± 2

25.2 ± 1

Ea (eV)

0.42 ± 0.02

0.33 ± 0.02

0.26 ± 0.01
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As noted, the desorption activation energies derived from Fig. 9.18 for the
protonated species are larger than those derived from Fig. 9.19 for the radical cations.
One possible explanation for this is that the form of the analyte within the porous
substrate leading to a protonated analyte is more tightly bound than the form of the
analyte leading to radical cation formation. Specifically, these results could be understood
if the protonated species are pre-formed in the solvent trapped within the pores and are
held tightly to the substrate via hydrogen bonding. On the other hand, the radical cations
are associated with the release of neutral molecules prior to ionization, which are held to
the substrate primarily through weaker van der Waals interactions. The source of the
proton leading to pre-formed protonated ions is not completely understood but there is
work that suggests the proton transfer in etched silicon is facilitated by the formation of
electrons and holes during laser irradiation [246].
The slopes of the ln(I) versus ln(F) plots (~4-5 when the laser focus is for
protonated ion and ~2-3 for molecular radical ion no matter where the laser focus is, as
shown in the Table 9.1) also suggest that the ionization mechanisms are different for the
protonated species and the radical cations. As shown in Fig. 9.2, the strongest radical
cation signals were observed when the incident laser was focused ~0.4 mm above the
surface of the substrate, In general, radical cations are seldom observed by MALDI or
SALDI. In this thesis a new ionization mode is therefore postulated to explain the
observation of radical cations and the strong dependence of the ion signal on the position
of laser focus relative to the substrate surface. The new process shown schematically in
Fig. 9.20 is called Surface Assisted Multiphoton Ionization (SAMPI), and appears to be
generic for every nanostructured semiconducting substrate examined to date.
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At the surface the SALDI spectra are dominated by the formation of protonated
species. Although the desorption process also yields neutrals the weak radical cation
signals suggest that most of the laser energy is absorbed by the substrate. However, as the
laser focus is moved above the surface the fluence at the surface decreases because of an
increase in the laser spot area. If the laser focus is too far away the fluence will be too low
at the surface to initiate desorption. Furthermore, the number of neutrals entering the laser
focal volume will be less as the density of plume decreases (due to the expansion). Under
the experimental conditions in this thesis placing the laser focus d = 0.4 mm above the
substrate corresponds to the optimum distance where there is still a relatively large
fluence at the surface for desorption and a large number of neutrals entering the laser
focal volume to be ionized by multiphoton ionization.
The electronic structure of caffeine (IP, ~7.9 eV [268]) has been studied. The
molecule has a strong π – π* transition at 35246 cm-1 (4.34 eV) which lies higher in
energy than the photon energy of the N2 laser. At the two photon level Rydberg states are
expected to be present which can facilitate (2+1) resonance enhanced multiphoton
ionization [269]. The cations are not expected to be cold because as described above the
plume is probably at best a weak adiabatic expansion. Hence, hot band transitions within
the focal volume could also contribute to the ion signal. Both effects could be operative.
Regardless, one would expect that the ln-ln plots of caffeine radical cation signal intensity
versus fluence to have a slope of ~ 2 as observed.
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Fig. 9.20: A schematic diagram showing the Surface Assisted Multiphoton
Ionization (SAMPI) process. Aad and Ag correspond to adsorbed and gas-phase
analyte molecules, respectively.
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Chapter 10: Conclusions and future work
10.1: Conclusions
The proceeding chapters have described the progress made in development and
applications of NIMS. This work involves four essential directions: (1) the fabrication
and characterization of pSi substrates for NIMS, (2) the development of functional
fluorous affinity NIMS chips for biological/biomedical applications, (3) an exploration of
new micro/nanostructured substrates and laser sources for NIMS, and (4) an investigation
of the relationship between laser fluence and the desorption ionization mechanism,
The thesis was presented as follows:
(1) In Chapters 2 and 3, a home-made apparatus, constructed to produce pSi for
NIMS applications, was described. The electrochemical etching parameters for
fabricating pSi were optimized at room temperature to obtain the best possible NIMS ion
signals. The best values of the current density, etching solution concentration and etching
time were found to be 45 mA/cm2, 50% HF acid concentration in ethanol by volume, and
30 minutes, respectively.
The performance of pSi-based NIMS using BisF17 as initiator was evaluated by
detecting the protonated polypeptide Dalargin, and comparing those results with the
signals obtained by DIOS MS. The LOD of (0.64  0.03) fmol for Dalargin by NIMS
represents an improvement of ~2000 x over the DIOS value measured with the same mass
spectrometer. Experiments showed that compared to DIOS MS, NIMS yields spectra with
a higher S/N ratio, is a more sensitive analysis technique and exhibits better
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reproducibility because the pSi substrate surface is more stable with the initiator coating
under ambient conditions.
A wide range of biological and pharmaceutical compounds were also analyzed in
order to determine the versatility of this method. It was demonstrated that NIMS can be
used to detect small molecules that exhibit different ionization modes. For example,
Fluorouracil (LOD: (4.8 ± 1) × 10-16 mol) and Quinidine (LOD: (1.0 ± 0.1) × 10-15 mol)
were detected as radical cations. The peptide Bradykinin (LOD: (7.1 ± 1) × 10-16 mol)
was readily detected as a protonated species. The steroid Dexamethasone (LOD: (1.7 ±
0.2) × 10-14 mol) and sugar-containing drug Erythromycin (LOD: (7.5 ± 0.6) × 10-14 mol)
were detected as metal cation adducts.
(2) In Chapter 4, fluorous-affinity NIMS chips were used to effectively separate
and enrich on-chip cysteine-containing peptides from mixtures. Specifically, the fluorous
affinity tag 3-(perfluoroalkyl) propyl-1-maleimide was used to bind a peptide containing
a cysteine residue from mixture of three peptides to a NIMS chip. The mass spectra
obtained after washing could be readily interpreted, and unlike rigid covalent surface
attachment strategies, fluorous-phase non-covalent immobilization may enhance
enzymatic activity by providing conformational flexibility.
The signal intensity of the tagged peptide was examined as a function of binding
reaction time, temperature and the washing solution composition. The best conditions
were found to be a binding reaction time of 60 minutes at 60

followed by a washing

step using 40% methanol in water solution. The utility of NIMS chips for the analysis of
complex biological samples was further demonstrated by enriching and subsequently
analysing cysteine-containing peptides from a BSA tryptic digest. Unlike classic
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bioaffinity reagents, the methodology in this work provided mass spectral results which
were relatively easy to interpret.
Chapter 5 examined the capability of fluorous-affinity NIMS chips on enzyme
assays. Specifically, the products formed by the reaction of peptide substrates with kinase
PKA, could be directly determined by mass spectrometry. It was also shown that PKA
enzymatic inhibition could be quantitatively screened in a combinatorial fashion. The
validity of using fluorous-affinity NIMS to quantitatively analyse enzymatic inhibition
was confirmed by deriving the IC50 values of two inhibitors and comparing them with
those obtained by other methods. A NIMS approach in this regard is more reproducible
than MALDI MS because the sample is evenly distributed on the chip surface, and the
mass spectra are clear of any interfering matrix ions and adduct ions.
Chapter 6 describes a new NIMS technique to determine the enantiomeric excess
of stereoisomers by kinetic resolution. The experimental results showed that the
enantiomeric excess could be determines within ± 10% which may be sufficient to meet
the the requirement for screening asymmetric catalysts. Compared to GC/HPLC-ESI-MS
over a chiral stationary phase, the chip-based NIMS strategy takes less time, is more
tolerant to buffer components, impurities and other potential contaminants, needs less
reagents, and involves an easier sample preparation.
(3) Chapter 7 demonstrates that the NIMS spectrum of peptide (Dalargin) using
BisF17 as initiator can be obtained by irradiating pSi with the 532 nm output of a
frequency-doubled Nd-YAG laser. Compared to visible-MALDI MS, visible-NIMS
yields mass spectra with higher S/N ratios and is a more sensitive analysis technique with
the LOD of (31+7) fmol. The results suggest that visible-NIMS can be carried out reliably
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using robust and increasingly inexpensive lasers such as the frequency-doubled output of
a Nd-YAG laser at 532 nm.
It was also demonstrated that good NIMS mass spectra could be obtained using
microstructured WO3 and porous TiO2 substrates although the results were not as good as
those obtained using pSi. However, metallic materials may be able to compensate for the
known mechanical and chemical fragility of pSi.
(4) Chapter 8 summarizes some recent advances in our understanding of the
desorption/ionization mechanism of MALDI, DIOS and NIMS. Models have been
proposed to explain both the desorption process, and a two-step ionization mode where
primary ions are formed during or shortly after the laser pulse which then undergo
secondary gas-phase reactions in the expanding plume of desorbed material. Some key
parameters influencing the desorption and ionization processes are described including
the effect of the laser wavelength, the role of the matrix/substrate in absorbing the
incident laser energy, the dependence of desorption/ionization on laser fluence, and
sample preparation protocols.
In Chapter 9, the SALDI mechanism was investigated for several substrates by
measuring the ion signal, I, as a function of laser fluence, F. Plots of ln (I) versus 1/(T0 +
ηF) were constructed for pSi, WO3 and TiO2 for the case when the incident laser focus
was located at the surface of substrate, and when the laser focus was located d = 0.4 mm
above the substrate surface. The plots support the premise that desorption is driven by a
thermal process. Desorption activation energies were derived from the plots.
The slopes derived from ln-ln plots of the protonated ion signals assuming an
dependence were ≥ 4 when the laser focus was placed at the surface of substrate,
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which also supports a thermal desorption mechanism. However the surprising observation
of radical cations when laser focus was located above the surface (d = 0.4 mm) suggests a
new ionization mechanism is operative which in this work is called Surface Assisted
Multiphoton Ionization (SAMPI). The SAMPI mechanism which appears to be generic
for all the porous SALDI substrates studied in this thesis and may prove to be useful for
delivering biomolecules into the gas-phase for spectroscopy.
10.2: Future work
Two future directions should be considered. The versatility of NIMS can be
enhanced by developing new fluorous affinity tags which are highly selective for specific
chemical functionalities. For example, hydrazine-containing fluorous affinity tags can be
used to separate and enrich glycopeptides or carbohydrates in biofluids, which serve as
biomarkers for a variety of important biological functions, including cell communication,
immune response, tumor metastasis, and so on [283].
The Lipson research group has expertise in the generation and use of coherent
VUV light at 118.2 nm (the third harmonic obtained by tripling the 355 nm output of a
Nd:YAG laser in Xe gas) extensively to soft-ionize a variety of volatile species such as
xanthate ester mixtures [284] and a selection of organic compounds with different
functional groups [285, 286]. In almost every case, the resultant soft ionization of a
neutral species results in parent ion formation with minimal fragmentation. Recently,
attempts were made in the Lipson lab to combine the high sensitivity of VUV laser single
photon ionization (SPI) with of MALDI and DIOS, and some satisfactory results for gasphase molecules were obtained. One could expect that combining laser SPI with the
excellent desorption capabilities of SAMPI could significantly enhance the efficiency of
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radical cation formation for non-volatile species by directly ionizing the expanding plume
with a second laser after an appropriate time delay.
A similar two-laser pump probe experiment using tunable UV or VUV laser
sources could also open up a powerful means of recording high resolution molecular
spectra of non-volatile biomolecules. If these species could themselves be ionized by
resonance ionization methods, the sensitivity of analyte detection should be significantly
improved. The one drawback would be that the desorbed molecules from SALDI
substrates may be hot leading to more congested spectra than one would anticipate using
supersonic jets. However, the routes to gas-phase biomolecules are limited and so the
SALDI methods described in this thesis would represent a significant advance.
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